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ABSTRACT
A major cause of the high risk of infection following implantations is that the
biomaterial implanted provides a surface for the bacteria to adhere and form a
biofilm [1]. Altering the surfaces of biomaterials being implanted in the body has
been a topic of interest in biofilm prevention research. In this proposed study, the
implant surfaces are modified with two proprietary surface modification
techniques, CoBlast™ and BioDep™ (ENBIO, Dublin, Ireland). The ambient
temperature CoBlast™ technique sprays a stream of abrasive particles such as
alumina with or without a dopant such as polytetrafluoroethylene (PTFE) to
permeate the surface of materials such as metals at a micron level [2]. The BioDep™
process involves a plasma deposition of biomolecules such as chitosan and
vancomycin at an ambient temperature, so antibiotic can reach the area of interest
locally.

Material characterization assessments examined the surface roughness, wear
resistance, and wettability of the CoBlast™ and BioDep™ surface modifications. The
surface roughness of stainless steel and titanium alloy samples could be directly
affected by the particle size of the abrasive used in the CoBlast™ process and was
not significantly affected by the BioDep™ deposition. The CoBlast™ surface
modification also successfully improved the wear resistance of the samples,
regardless if their base material was stainless steel or titanium alloy. Finally, the
inclusion of the dopant PTFE in the CoBlast™ process increased the hydrophobicity
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of the samples, regardless of their base material. All of these characterizations
influenced recommendations for parameters for different future applications of
these surface modification techniques.

In vitro analysis of the BioDep™ deposition process yielded recommendations for
the animal study to follow. BioDep™ successfully deterred bacteria from the surface
of the material regardless if the surface below it was an unmodified stainless steel
or titanium sample or a CoBlast™ modified sample, however the degree to which it
was effective was dependent on the number of layers of BioDep™ applied. An
increase in number of layers increased the zone of inhibition that formed around the
samples, however eventually too many layers caused manufacturing concerns. It
was decided that a 9-layer option deposited at a high power setting was the optimal
BioDep™ treatment for implants in the animal study.

The animal study examined the efficacy of an unmodified titanium dynamic
compression plate (DCP), a titanium DCP modified with an alumina-only CoBlast™
process and a 9-layer high power BioDep™ coating of chitosan + vancomycin, and an
unmodified titanium DCP with a 9-layer high power BioDep™ coating of chitosan +
vancomycin at preventing biofilm formation after 28 days implanted on a rabbit
femur. The implants with the BioDep™ coating all successfully prevented bacterial
adhesion whereas the unmodified titanium implants did not.
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CHAPTER ONE:
GENERAL INTRODUCTION

Deep infections following orthopaedic surgery have been found to be correlated
with the use of biomaterials [3]. Biomaterials are used in many orthopaedic
surgeries, such as total joint replacements and fracture fixation cases. There are
about 1 million hip and knee joint replacements performed each year in the U.S. [4,
5], with that number expected to rise to 4 million by the year 2030 [6, 7]. In
addition, in the U.S. there are 3.5 to 6 million fractures annually [8, 9] and nearly
500,000 of those in 2010 were open reduction fractures requiring internal fixation
[10]. Infection rates in hospital surgeries requiring the implantation of orthopaedic
devices have been reported anywhere between 0.5 and 50% [11, 12, 13, 14, 15],
with infection rates associated with fracture fixation depending on the severity of
the type of fracture [16, 17, 18, 19]. These infection-prone fractures are not a
unique problem to the civilian population. Looking at numbers surrounding the
battlefield, injuries to the extremities account for over 75% of all injuries in modern
war with over one-third of those injuries consisting of bone fracture [20], and up to
91% of all battlefield wounds resulting in infection [21].

Infections cause patients hospital stays to last on average 6.76 days longer and
making the cost of hospital care for patients with infections is nearly $30,000,
compared to non-infected patients being around $10,000 [12].
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Most of these

infections in open fracture cases are caused by Staphylococcus aureus [22], with S.
aureus being the major pathogen found in metal implant infections, as opposed to
Staphylococcus epidermidis being found most commonly in polymer implant
infections [23]. A major cause of the high risk of infection following implantations is
that the biomaterial implanted provides a surface for the bacteria to adhere and
form a biofilm [1].

Both bacteria and surface characteristics have been found to greatly affect the
likelihood of bacterial adhesion. Bacteria adhere differently to the same material
depending on their species and strain [23], and although the hydrophobicity of
bacteria varies, it has been found that those with hydrophobic properties prefer to
adhere to hydrophobic surfaces, and hydrophilic bacteria prefer hydrophilic
surfaces [23, 24, 25, 26, 27]. Hydrophobic bacteria adhere more than hydrophilic
bacteria [28, 29, 27] and it has been found that the hydrophilic capsules present on
bacterial cells reduce adhesion [30, 29, 31]. Hydrophobic surfaces are less resistant
to bacterial adhesion than hydrophilic materials [29, 32, 24, 11]. The surface
properties also greatly affect the likelihood of bacterial adhesion [24, 26, 33, 19]. In
general, the higher the surface free energy [24], the rougher the surface is [25, 34,
35, 36, 37], the more porous the material is [24, 38], and the more hydrophobic a
material is [11, 29, 24, 32], the more likely it is for bacteria to adhere to the surface.
Mechanisms to determine these surface properties will be demonstrated in the
methods section.
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The combination of an implant surface that discourages bacterial adhesion and an
implant coating that releases a local antibiotic could be a promising approach to the
management of biofilm formation and growth in surgeries that are prone to
infection, such as open fractures requiring internal or external fixation. We are
proposing the deposition of vancomycin on a fracture fixation implant that is
resurfaced with an alumina and PTFE surface modification technique to minimize
bacterial adhesion and therefore make the fracture site less susceptible to infection.
1. White
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CHAPTER TWO:
RESEARCH OBJECTIVES

There is a significant amount of room for research in the field of infection
prevention and management in orthopaedics, however this research focuses on the
development and characterization of a particular treatment option. The primary
objectives of this research are to:

Aim 1: Examine changes in material characterization assessments of stainless steel
and titanium alloy samples after the implementation of the CoBlast™ and BioDep™
surface modification processes, including examination of surface roughness, surface
energy, and wear resistance.
The CoBlast™ surface modification technique is a newer process that has been used
in limited biomedical applications thus far. BioDep™ is another newer technique
using plasma and biomolecules to form a bonded coating on a wide range of medical
devices. Characterizing the modification to surfaces commonly used in fracture
fixation such as stainless steel and titanium alloy could help identify ideal
biomedical and potentially other alternative applications.

Aim 2: Examine the variation in treatment parameters in an in vitro setting to
determine how these changes affect the ability of the implant to inhibit biofilm
formation.

4

CoBlast™ and BioDep™ both have potential antimicrobial properties that should be
evaluated with various bacterial studies. The powder composition used in CoBlast™
can include polytetrafluoroethylene (PTFE) which may have an effect on the
likelihood of bacterial adherence, and BioDep™ uses chitosan, which has shown
occasionally in literature to have an antimicrobial effect, and vancomycin, a common
antibiotic that has been shown to decrease the prevalence of infection. The BioDep™
process can deposit multiple layers, therefore increasing the volume of substance it
is depositing on the surface. The traditional deposition of vancomycin includes a
single layer deposited at 150V, however strength of power as well as amount of
layers can be varied to provide different parameters to compare and evaluate.

Aim 3: Examine the effectiveness of these modifications in an in vivo environment
using a rabbit animal model.
In vitro environments can only show the effectiveness of the surface modifications
to a certain extent, and are not necessarily indicative of how the body will react.
Animal models are used to test the proposed modifications in a live environment
before using the treatment on humans. Rabbit animal models are ideal for fracture
fixation studies due to their relatively small size but large leg bones such as their
femurs. Identifying the optimal surface modification combination in an in vivo
environment is a necessary step.
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CHAPTER THREE:
MATERIAL CHARACTERIZATION

Background
Implants used in orthopaedics may be used for fracture fixation or load bearing
applications such as joint replacements. Common materials used in orthopaedics
include metals such as a titanium alloy (Ti-6Al-4V), stainless steel, and Co-Cr-Mo,
ceramics (alumina, hydroxyapatite, and zirconia), and ultrahigh-molecular weight
polyethylene (UHMWPE) [39]. The materials used in these implants are often
directly related to the intended function. Ceramics are useful for bearing surfaces
because of their hardness whereas titanium alloys are more often used on nonbearing surfaces because of their similarity of stiffness to bone, resulting in less
stress shielding [40]. Regardless of the material, surface modifications can be
performed to alter characteristics of the base material to better fit the desired
application, such as a medical implant that resists the adhesion of bacteria.

CoBlast™ surface modification technique
In this proposed study, the implant surfaces are modified with two proprietary
surface modification techniques, CoBlast™ and BioDep™ (ENBIO, Dublin, Ireland).
The ambient temperature CoBlast™ technique sprays a stream of abrasive particles
with or without a dopant to permeate the surface of materials such as metals at a
micron level [2]. The powder compositions used for the abrasives or dopants can
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vary widely. This can include using varying sized particles, hydroxyapatite, alumina,
PTFE, and silicon carbide (SiC) to name a few [2]. The abrasive particles are used
not to embed into the surface, but to roughen it to allow enhanced adhesion of the
dopant [41, 42, 43]. This surface modification process is designed to improve wear
resistance depending on the materials used and is hypothesized to additionally
deter bacterial adhesion [2]. With the use of PTFE as a dopant as proposed in this
study, it is likely that the wear resistance advantage of the CoBlast™ modification
process will be compromised since PTFE has a high rate of wear despite its low
coefficient of friction [44].

BioDep™ plasma deposition
The presence of an antibiotic on the surface of a material has been shown to
strongly decrease the likelihood of bacterial adherence [45], which is why coating
an implant in antibiotics has been seen as a very viable option to fight local infection
following implantation. In this research, chitosan and vancomycin will be deposited
on the surface of the implants. Chitosan, made by the deacetylation of chitin, has
many applications and has been shown to have varying degrees of antimicrobial
activity [46, 47, 48, 49]. In addition to its antimicrobial properties, it has been
shown to promote bone growth [50, 51] and can be used for drug delivery [52, 53].
Antimicrobial activity is more promising with the controlled release of a drug like
vancomycin [49]. Vancomycin has also been used on its own to limit bacterial
adhesion to titanium surfaces [54].
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The BioDep™ process involves a plasma deposition of biomolecules at an ambient
temperature. This technology cross-links the biomolecule and bonds the substrate
to the material [55]. This non-cytotoxic chemical process uses a low energy plasma
source to create a layer of coating that only contains the biomaterial of interest [55].

There are several characteristics of a material that make it more or less prone to
bacterial adhesion. These surface properties can include the material chemical
composition, its hydrophobicity, roughness, surface free energy, charge, and
porosity [56, 45]. Many of these characteristics will be explored and evaluated in the
proposed research study.

Surface roughness
Surface roughness can be measured by examining the roughness profile of a surface,
or the profile created as a result of filtering the primary profile of the surface with a
cut-off wavelength λ c [57]. The roughness can be calculated in many different ways,
including examining it via the arithmetical mean roughness value (Ra), which is the
average of the absolute values of the deviations in the profile from the mean line of
the roughness profile, the root mean square roughness (Rq), or the root mean
square average of the roughness profile, the total height of the roughness profile
(Rt), which is the difference between the height of the highest peak and valley, or
the mean roughness depth (Rz), where the average of the five values with the
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highest peaks and lowest valleys is made [58]. Profiles for these parameters can be
seen in Figure 1 and Figure 2.

Figure 1: Profile showing Ra, the arithmetical mean roughness value [57]

Figure 2: Rt, the total height of the roughness profile, and Rz, mean roughness depth [57]

Contact and non-contact profilometers are often used to determine the roughness of
a surface. Non-contact profilometers, or optical profilometers, have several benefits
compared to contact profilometers, mainly in that they do not need a diamondtipped stylus to measure the surface profile. This stylus can damage or alter the
surface of the material permanently and is not always a viable option. In addition,
optical profilometers are capable of not just measuring a line profile that measures
the height, but an entire area of the surface allowing for more surface information to
be gathered. This allows the machine to create a 3D measurement of the surface and
can calculate volumes of bumps and voids, which can be of great use in the
evaluation of a surface after wear testing [59].

Wear
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Wear is the removal of a material by its interaction with another material, be that by
microfracture, chemical dissolution, or by contact interface melting [60]. It is not an
innate property of the material of interest but instead an interaction between two
materials and the response to the system as a whole. There are several types of
wear, however the most fundamental are generally defined as adhesive, abrasive,
fatigue, and corrosive [61]. Pictorial representations of these wear modes can be
seen in Figure 3.

Figure 3: Four wear modes [60]

Wear does not occur via one particular mechanism, rather the type of wear can
change during the contact between the two materials due to changes in the
materials’ surface properties and the response of the materials to the frictional
heating, wear, and chemical film formation that occurs as a result of their contact
[60].
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Some materials, such as titanium alloys which are commonly used in many
applications such as orthopaedic applications due to their attractive strength and
weight, are some of the least impressive metals in wear resistance over a wide range
of temperatures. However, there are several factors that can affect the wear
properties of a material, including the environmental conditions such as
temperature, load, and velocity of the interacting materials. Changing any one of
these factors during testing can significantly alter the outcome of the wear testing.
There are several tests that can be used to help determine how a material would
interact with another in various scenarios in which wear would be experienced. Pinon-disk wear testing abrades two materials, one a fixed ball bearing machined into a
pin, and the other the material of interest machined into a disk. Standards in place to
describe these tests include ASTM G99, ASTM G133, and ASTM F732. A linear wear
test similar to the pin-on-disk testing method was used in this research due to the
limited capabilities of the materials testing machine available (CETR UMT-2). This
test can help determine wear rates and frictional force coefficients and a benefit to
this testing setup is that the environment created can more accurately simulate a
more realistic wear condition, such as elevated temperatures or submerged in a
lubricant [62]. Blade-on-block wear testing uses an object that articulates with a
stationary specimen (the block and blade, respectively) under a constant normal
load. This method of wear testing is used when a higher load of force is needed than
can be done in pin-on-disk testing or if nonstandard environmental conditions are
needed [62]. Wear testing can also be done with specific applications, such as
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medical applications, in mind. Longer term wear testing is often done on medical
implants to characterize the tribological properties of the device and the standards
for these devices vary by types: hip prostheses (ISO 14242-3), total knee
replacements (ISO 14243), spinal devices (ISO 18192 and ASTM F2423) as well as
small bone and joint replacements (various standards).

Wettability
One notable surface characteristic of interest is the hydrophobicity, since it has been
shown that hydrophobic materials are more favorable to bacterial adherence than
hydrophilic materials [45]. It has also been found that hydrophobic bacteria prefer
hydrophobic materials, just as hydrophilic bacteria prefer hydrophilic surfaces [45].
S. aureus, the bacteria to be used in this research as it is the most prevalent bacteria
found in orthopaedic infections [63], is hydrophobic [64]. It has also been shown
that the surface roughness affects the likelihood of bacterial adherence, with a
rougher surface being more liable to attachment, possibly due to the increase in
surface area [45].

There is always a surface tension that exists between a fluid and a solid and when
there are two things in contact with the surface of a solid, the equilibrium
configuration of their phases depend on the surface tension relative values between
each of the three phases [65]. Each surface tension defines the wetting angle, or the
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angle of the interaction of the liquid to the solid surface in the presence of a gas, as
seen in Figure 4.

Figure 4: Liquid/solid/gas wetting angle [65]

The wetting angle, or contact angle, is the measure of wettability of a solid by a
liquid. Complete wetting, or spreading, results in a contact angle of 0˚. While the
contact angle is between 0 ˚ and 90 ˚ the solid is considered wettable, or hydrophilic,
and above 90 ˚ not wettable, or hydrophobic.

There are several methods established to measure the wettability of a solid. The
Wilhelmy plate method measures the force in the tensile direction of a plate-shaped
solid is moved vertically in a liquid. This force will depend on the surface tension,
the wetted length, and the contact angle [66]. The Washburn method can help
determine the powder contact angle measurement where the increase in the weight
of a powder-filled tube that is immersed is measured over time. The rate in which
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the liquid column rises depends on the contact angle [66] . The drop shape analysis
method measures the contact angle by taking an image of a sessile drop on the
surface of the solid and uses a baseline projection to measure the angle of phase
interaction [66].

Contact angle testing is done to determine the wettability of a solid in a neutral
environment, however it is also important to consider the end application of the
material when setting up the testing. Biomaterials placed in the body are affected by
protein adhesion immediately after implantation, and this can affect the interactions
with other components such as bacteria [67, 68, 69]. Both the wettability and
surface chemistry of a material influence changes in adsorbed proteins and mediate
binding strengths [70, 71, 72]. Protein-fouling the surface prior to wettability testing
can more accurately represent the material in an application in the body, as would
occur with biomaterials used in medical applications. An example of a protein to be
used in wettability testing to accurately simulate conditions in the human body is
human serum albumin (HSA). This protein is chosen as it is the most abundant
protein in human blood plasma [73].

Research Outcomes
The goal of this aim was to make material characterization assessments of the
CoBlast™ and BioDep™ processes on stainless steel and titanium alloy Ti-6Al-4V
samples. First the hypothesis that surface roughness can be altered using various
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particle sizes of the abrasive used in the CoBlast™ modification technique was
explored. Secondly we tried to determine if the CoBlast™ treatment will improve the
wear resistance of the sample regardless of the base material. Finally, whether the
CoBlast™ technique or the BioDep™ plasma deposition alter the hydrophobicity of
the base material was studied.

Optical Imaging and Specimen Introduction
Initial samples were sent to Clemson University from ENBIO (Dublin, Ireland) for
verification of their testing and analysis equipment. Optical microscopy was first
used to characterize the surface morphology of the samples made by ENBIO. Ten
grade 5 (G5) titanium discs (diameter 1 cm), 1 G5 titanium disc (diameter 2.54 cm),
both pictured in Figure 5, 9 stainless steel 316 discs (diameter 1 cm), and 1 stainless
steel 316 disc (diameter 2.54 cm), pictured in Figure 6, were obtained from ENBIO
and photos were taken of all samples upon arrival (Nikon D5100).

A previously

obtained coated stainless steel 316 rectangular bar (9.2 cm x 3.8 cm x 0.55 cm) is
also pictured in Figure 7. A labeling system of samples was developed, however not
implemented for these blank samples. The labeling system that will be used for the
remainder of this research is as follows:
First character:
T = titanium alloy (Ti-6Al-4V) base substrate
S = stainless steel base substrate
Second character:
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B = blank; no CoBlast™ modification
A = alumina only used in CoBlast™
P = alumina with polytetrafluoroethylene (PTFE) used in CoBlast™
Third character:
5 = 50 µm abrasive particle used in CoBlast™
9 = 90 µm abrasive particle used in CoBlast™
Subsequent characters:
C = CoBlast™
X = chitosan only deposited in BioDep™ process
V = vancomycin and chitosan deposited in BioDep™ process
# after V = denotes the number of layers of BioDep™ applied, with HP indicating the
“high power” option used

Figure 5: 10 G5 titanium 1 cm diameter samples (left) and 1 G5 titanium 2.54 cm diameter

sample (right)
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Figure 6: 9 stainless steel 316 1 cm diameter samples (left) and 1 stainless steel 316 2.54 cm diameter
sample (right)

Figure 7: PTFE CoBlast™ coated stainless steel 316 sample

A summary of the parameters that were evaluated can be best seen in Figure 8.
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Figure 8: Summary chart of all parameters evaluated and their abbreviated nomenclature

Throughout this research, surface roughness, wettability, zone of inhibition testing,
and literature review will contribute to the elimination of treatment options from
this chart to determine the treatments to test in the in vivo model.

Surface Roughness
Surface roughness is critical in the formation of biofilms and adhesion of bone to
implant surfaces. Surface roughness of the circular 2.54 cm samples as well as
previously obtained rectangular coated samples (9.2 cm x 3.8 cm x 0.55 cm) was
analyzed using a white light interferometer (Wyko NT-2000). The original stainless
steel coated sample was tested at 18 locations evenly distributed across the
rectangular bar. With a magnification of 25x and intensity of 47, the field of vision
was 0.216 mm x 0.164 mm. A backscan of 5 μm and length of 40 μm was used
during testing. Using vertical scanning interferometry, results were found in
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micrometers as shown in Table 1 and standard deviations and averages can be
found in Table 2. The locations of surface roughness analysis shown in Table 1 can
be seen in Figure 5.

Table 1: Surface Roughness (μm) of Coated Stainless Steel 316 Sample

Ra
Rq
Rz
Rt
Ra
Rq
Rz
Rt
Ra
Rq
Rz
Rt

1.93
2.43
19.0
20.7
2.14
2.77
21.4
23.7
2.04
2.66
26.3
27.2

2.23
2.82
23.2
24.9
2.57
3.24
26.0
27.5
2.57
3.15
21.7
25.4

2.04
2.59
18.9
21.1
2.31
2.91
20.4
22.5
2.01
2.53
18.7
20.7

2.07
2.61
20.1
23.5
1.94
2.41
19.2
22.7
2.31
3.02
22.2
24.7

2.12
2.71
20.0
21.7
2.16
2.87
23.5
24.4
2.73
3.41
24.8
30.7

2.01
2.53
18.4
19.6
2.38
3.02
19.6
21.7
1.79
2.31
16.7
18.3

Table 2: Surface Roughness averages and standard deviations (μm) of Coated stainless steel 316

Sample

Ra
Rq
Rz
Rt

Average
2.19
2.78
21.1
23.4

SD
0.251
0.305
2.73
3.08
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Figure 9: Location of surface roughness analysis of the coated stainless steel 316 sample

This evaluation of the bar was our first insight into the roughness of the CoBlast™
modification, and verified that the Wyko optical profilometer in the laboratory was
capable of analyzing these surfaces. The following measurements showed that we
were capable of measuring the surface roughness of the circular samples provided
by ENBIO. The circular stainless steel blank sample was tested at 13 locations
evenly distributed across the smoother side of the sample in a grid formation. With
a magnification of 25x and intensity of 42.600, the field of vision was 0.216 mm x
0.164 mm. A backscan of 5 μm and length of 40 μm was used during testing. Using
vertical scanning interferometry, results were found in micrometers as shown in
Table 3. A change in orientation of analysis is shown in Figure 10 due to a circular
geometry of the blank samples. Standard deviations and averages are shown in
Table 4.
Table 3: Surface roughness (μm) of blank stainless steel 316 sample

Ra
Rq
Rz
Rt

0.599
0.741
4.51
5.17
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Ra
Rq
Rz
Rt

Ra
Rq
Rz
Rt
0.606
0.760
4.79
5.33
Ra
Rq
Rz
Rt

0.531
0.675
5.17
7.04
0.934
1.11
5.68
5.96
0.518
0.652
4.08
4.39
Ra
Rq
Rz
Rt

0.790
0.953
5.42
5.79
0.323
0.412
3.44
4.33
0.478
0.612
4.66
5.06
0.766
0.980
5.61
6.09

1.10
1.33
6.74
7.36
0.685
0.861
6.35
6.94
0.522
0.658
4.84
5.3

0.659
0.826
5.04
5.75

Table 4: Surface roughness averages and standard deviations (μm) of blank stainless steel 316 sample

Ra
Rq
Rz
Rt

Average
0.655
0.813
5.10
5.73

SD
0.205
0.239
0.888
0.952
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Figure 10: Location of surface roughness analysis stainless steel 316 blank sample

The circular G5 titanium blank sample was tested at 13 locations evenly distributed
across the smoother side of the sample in a grid formation. With a magnification of
25x and intensity of 42.600, the field of vision was 0.216 mm x 0.164 mm. A
backscan of 5 μm and length of 40 μm was used during testing. Using vertical
scanning interferometry, results were found in micrometers as shown in Table 5 in
the orientation shown in Figure 11 and averages with standard deviations are found
in Table 6.
Table 5: Surface roughness (μm) of blank G5 titanium sample

Ra
Rq
Rz

Ra
Rq
Rz
Rt
0.902
1.02
4.49

0.746
0.851
3.93
4.27
0.831
0.961
5.38

0.755
0.849
4.35
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Rt
Ra
Rq
Rz
Rt

0.703
0.815
3.77
4.05
Ra
Rq
Rz
Rt

5.68
0.779
0.958
7.39
8.04
0.850
0.964
4.10
4.59
Ra
Rq
Rz
Rt

5.92
0.748
0.853
4.44
4.96
0.747
0.859
4.31
5.20
0.748
0.869
4.93
5.53

4.67
0.789
0.980
5.06
5.59
0.886
0.990
5.13
6.15

0.708
0.841
3.89
4.48

Table 6: Surface roughness averages and standard deviations (μm) of blank G5 titanium sample

Ra
Rq
Rz
Rt

Average
0.784
0.909
4.71
5.32

SD
0.064
0.070
0.954
1.05

Figure 11: Location of surface roughness analysis G5 titanium blank sample
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CoBlast™ modified samples with varying parameters were then received from
ENBIO. Parameters included the particle size of the alumina abrasive used (50 µm
vs. 90 µm) and the presence or absence of the dopant polytetrafluoroethylene
(PTFE). Surface roughness analysis was done on all larger square samples (2.54 x
2.54 cm) and any smaller samples that were to be later used for biofilm growth
(diameter = 1 cm). Comparisons in surface roughness between 5 larger samples of
either stainless steel or titanium alloy in each category (50 µm grit alumina only, 90
µm grit alumina only, 50 µm grit alumina + PTFE, and 90 µm grit alumina + PTFE)
were made with the blank side of a sample from each category. This yielded 20
stainless steel coated samples, 4 stainless steel blank samples, 20 titanium alloy
coated samples, and 4 titanium alloy blank samples. The results of the larger
samples are as follows:
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Table 7: Titanium alloy
sample
surfaceMeasures
roughness
for larger
Surface
Roughness
forresults
Specimens
(um) sample series

TA5C_M01
Ra
Rq
Rz
Rt

1
0.91054333
1.16833333
10.3516667
11.945

2
0.92
1.20
11.11
12.56

3
4
5 Averaged
StDev
0.92 0.91938667 0.96713167 0.92843567 0.0221885
1.20 1.18333333 1.26166667
1.201 0.03575767
11.20 11.6783333 12.2733333 11.3226667 0.71293174
13.21
13.54 14.4516667
13.141 0.95462805

TA9C_M01
Ra
Rq
Rz
Rt

1
2.0017
2.5417
20.5550
23.3900

2
2.0017
2.5617
20.5483
23.0950

3
1.9950
2.5383
18.8067
21.2283

4
2.0950
2.6533
19.1167
21.4167

5
1.9817
2.5233
18.8183
21.4317

Averaged
2.0150
2.5637
19.5690
22.1123

StDev
0.0455
0.0520
0.9056
1.0400

TP5C_M01
Ra
Rq
Rz
Rt

1
1.5950
1.9233
12.4050
13.9983

2
1.5283
1.8900
13.2250
14.8550

3
1.6350
1.9633
12.5717
14.3167

4
1.5683
1.9217
12.5033
14.3350

5
1.5633
1.9250
13.3250
15.1100

Averaged
1.5780
1.9247
12.8060
14.5230

StDev
0.0397
0.0260
0.4337
0.4494

TP9C_M01
Ra
Rq
Rz
Rt

1
2.0817
2.6342
19.7250
20.9650

2
1.9217
2.4067
18.3283
20.7383

3
2.1283
2.6567
18.2200
20.4083

4
1.9650
2.4817
18.7600
20.9683

5
2.1550
2.7050
19.7917
22.1633

Averaged
2.0503
2.5768
18.9650
21.0487

StDev
0.1023
0.1266
0.7522
0.6638

TB_M01
Ra
Rq
Rz
Rt

TA5C
0.4718
0.5768
3.0650
3.3733

TA9C
0.2692
0.3336
2.7033
3.3150

TP5C
0.3380
0.4253
4.0867
4.8283

TP9C
0.4839
0.5990
3.9667
4.5083

Averaged
0.3907
0.4837
3.4554
4.0063

StDev
0.10456756
0.12636185
0.67771863
0.77595506
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Surface
Roughness
Measures for
Specimens
Table 8: Stainless steel
sample
surface roughness
results
for the(um)
larger sample series
SA5C_M01
Ra
Rq
Rz
Rt

1
1.0315
1.3183
11.7100
13.9633

2
0.9006
1.1583
11.0567
13.9600

3
0.9147
1.1750
10.6333
13.1667

4
1.5867
1.9317
13.0850
15.3183

5
0.9431
1.2117
10.5517
12.0717

Averaged
1.0753
1.3590
11.4073
13.6960

StDev
0.2903
0.3261
1.0441
1.1929

SA9C_M01
Ra
Rq
Rz
Rt

1
1.9817
2.5417
17.7600
19.6600

2
1.9850
2.5500
17.9517
19.5133

3
2.1883
2.7883
18.7967
20.6867

4
2.0250
2.5917
19.1033
20.8900

5
2.4400
3.0767
21.2050
23.6083

Averaged
2.1240
2.7097
18.9633
20.8717

StDev
0.1958
0.2283
1.3733
1.6460

SP5C_M01
Ra
Rq
Rz
Rt

1
1.3717
1.7117
13.3400
15.5983

2
1.4417
1.7900
12.6617
14.0367

3
1.4833
1.8217
12.4650
14.2467

4
1.4917
1.8383
12.9683
14.8317

5
2.0450
2.4933
15.2517
17.2833

Averaged
1.5667
1.9310
13.3373
15.1993

StDev
0.2716
0.3181
1.1201
1.3131

SP9C_M01
Ra
Rq
Rz
Rt

1
2.0617
2.5950
17.7100
19.3517

2
2.0567
2.6083
20.2100
23.0700

3
2.2050
2.7533
18.6567
20.4217

4
2.2583
2.8033
18.5900
20.4900

5
2.1933
2.7633
18.5850
20.0317

Averaged
2.1550
2.7047
18.7503
20.6730

StDev
0.0909
0.0960
0.9048
1.4142

SP9C_M01
0.7162
0.8987
5.4583
6.1067

Averaged
1.0095
1.2367
6.9804
7.6542

StDev
0.43912953
0.52415787
2.39122368
2.50176586

SB_01
Ra
Rq
Rz
Rt

SA5C_M01 SA9C_M01 SP5C_M01
1.1774
0.5946
1.5500
1.4150
0.7397
1.8933
7.7333
4.7217
10.0083
8.6767
5.1600
10.6733
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Figure 12: Graphical results of surface roughness values for 2.54 cm titanium alloy and stainless steel
samples

Comparisons in surface roughness between all samples, both coated and blanks,
used in biofilm growth studies were made. This yielded 51 stainless steel coated
samples, 22 stainless steel blank samples, 47 titanium alloy coated samples, and 22
titanium alloy blank samples. The results of these smaller (1 cm diameter) samples
are as follows:
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Figure 13: Graphical results of surface roughness values for titanium alloy and stainless steel samples
for smaller (1 cm diameter) samples

The larger circular samples varied extremely in roughness, as the machining
process done to obtain the larger samples was more crude on the stainless steel
samples.

These higher roughness values on the larger stainless steel samples

affected the surface roughness values if the grit used was fine (50 µm grit size)
however was sufficiently covered by the larger grit size (90 µm). This difference in
roughness of the blanks affected the values of the surface roughness of the coated
samples, as seen by the differences between the stainless steel and titanium alloy
bars in the graph. A general trend was that the alumina only samples were less
rough than the alumina + PTFE samples, and as expected the 50 µm grit coatings
were less rough than the 90 µm grit coatings. Examining the smaller samples, which
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had a higher sample size to analyze and less variation in blank surface roughness,
the samples were relatively consistent in surface roughness after being coated, with
the exception of the higher roughness of the titanium alloy showing through the 50
µm grit coatings. However, the same general trends were seen, with there being no
significant difference in roughness between the 90 µm alumina only coating and 90
µm alumina + PTFE coating.

Once samples with the BioDep™ modification were received from ENBIO, chitosanonly deposited samples were compared to regular CoBlast™ modified samples were
made. As a trend, the surface roughness increases with an increased particle size
(50 µm alumina grit vs. 90 µm alumina grit). Chitosan coatings in general do not
seem to be making the surface roughness change much, however the sample size for
chitosan-coated samples is much smaller than all other sample types.

29

Figure 14: Average surface roughness (Ra) for blanks, denoted with a “B”, CoBlast™ modified samples,
denoted with a “C”, and chitosan-deposited samples, denoted with an “X”

After vancomycin doped samples were received from ENBIO, all sample types that
were ever used in the bacterial research portion of this study, some of which is
presented later in this document, were measured for surface roughness as seen in
Table 9 and Table 10. 5 samples of each possible modification variety were
measured in 6 locations, as seen in Figure 15. These (n=30) results are shown
graphed in Figure 16.
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Table 9: Average Ra values for all variations of stainless steel samples used

Table 10: Average Ra values for all variations of titanium alloy samples used
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Figure 15: Locations of surface roughness measurements performed with the Wyko NT-2000 optical
profilometer

Figure 16: Average surface roughness values (Ra) of all samples used in biofilm and wettability testing

These average roughness (Ra) values for each of the sample varieties were
compared using a t-test. When comparing the roughness of the same coating on
different bases (i.e. Comparing TP5C and SP5C), there were statistically significant
differences between most samples. The modifications without significant
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differences between the base substrates were the P5CX, P5CV, P9CV, A5CV, A9C, and
A9CV samples. Further statistical analysis was done on samples with the titanium
alloy base, as this would be the base material of the implant used in the future
animal study, to be discussed later in the document. Most of these comparisons
were found to have a statistically significant difference, as seen in Figure 17.

Figure 17: Average roughness (Ra) comparisons of surface modifications performed on titanium alloy
samples

Discussion: Surface Roughness
Several sizes of materials were provided by ENBIO throughout this research study:
the 9.2 cm x 3.8 cm rectangular bar, the 2.54 cm diameter circular pucks, the 2.54
cm x 2.54 square samples, and the smaller 1 cm diameter samples used in
wettability and bacteria testing. Surface roughness analysis was initially done on the
bar to confirm that the lab equipment available was capable of analyzing this
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surface modification and gave us insight into how rough the samples with the
CoBlast™ modification were going to be. The circular pucks were originally intended
to be used for wear testing later in the study. However, after close examination, the
circular pucks were machined in such a way that small rings protruded from the
surface, not only yielding high roughness values for the stainless steel and titanium
alloy blanks, but were also large enough that the CoBlast™ modification did not
sufficiently cover these peaks and true surface roughness values could not be
obtained for the CoBlast™ layer. This led to the use of the square samples for large
materials testing and the small circular samples for bacterial testing, as they would
fit in well plates. These materials had uniform surface roughness values across the
samples and were used for final analysis of the surface roughness of our base
materials and the CoBlast™ modifications. It was found that the CoBlast™ surface
modification technique did roughen our blank samples, but the degree of increase in
surface roughness was directly affected by the particle size of the abrasive used in
the CoBlast™ process. 90 µm abrasive particles used in the CoBlast™ process yielded
a greater average surface roughness than did the 50 µm abrasive particles,
regardless if the dopant, PTFE, was present. It was also found that regardless of the
significant difference in surface roughness between the stainless steel and titanium
alloy blanks, the CoBlast™ process negated any significant roughness difference;
meaning once the CoBlast™ technique was applied, the surface roughness was no
longer significantly different between the two, regardless of the base material
underneath. Finally, it was found that the deposition of the chitosan and the
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chitosan + vancomycin from the BioDep™ process had no significant effect on the
surface roughness of the materials, both on the blanks and the CoBlast™ modified
samples. This means that if the surface roughness of the material is of concern for a
particular future application, the addition of the BioDep™ plasma deposition process
will not be an added factor in surface roughness.

The effect of surface roughness of a material on likelihood of bacterial adhesion has
long been studied, and many studies show that rougher materials promote bacterial
adhesion [45, 74]. Surfaces with an Ra value of ≤0.8 µm are less susceptible to
bacterial deposition [75]. Rougher surfaces are more prone to bacterial attachment
due to a few factors, including an increased surface roughness, a protection in the
crevices from shear forces, and surface irregularities that can protect the bacteria
during cleaning [76]. Bacteria still attaches to smooth surfaces, so an increase in
surface roughness is not the sole reason for bacterial attachment [77], however
changing the surface morphology has been seen to have an effect on the likelihood
of adherence. Boyd et al. found that S. aureus cells, which have a diameter of 0.5-1.5
µm [78], tend to attach strongest to surfaces of the same scale features [74].
Although it has not been extensively investigated, there is interest in examining the
effect of a nanoscale topography on cellular attachment. Some have found that there
is a greater level of attachment to surfaces with nanoscale features (<100 nm) [79,
80], while others have found these smaller features to be repellent [81, 82]. It is
possible that this discrepancy is from the varying sizes and shapes of various
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bacteria. Since the CoBlast™ surface modification technique has the ability to change
a wide range of the parameters involved, this is something that can be explored with
smaller and nanoscale abrasive particles.

Wear Testing
A script to scratch linearly from 1 N to 15 N was written to perform scratch testing
on each sample using a universal materials tester (CETR, UMT-2). The testing was
done in accordance to ASTM G133-05, with a scratch length of 10 mm using a 3/8”
tungsten carbide (WC) ball, as pictured in Figure 18. Three scratches were optically
viewed on a 2.54 cm diameter TP9C sample as seen in Figure 19.

Figure 18: 3/8” tungsten carbide (WC) ball bearing

Figure 19: Optical image of TP9C large sample after preliminary wear testing

Each ball bearing was viewed with an optical microscope to verify there was no
damage from manufacturing and surface roughness was recorded with the optical
profilometer (Wyko, NT-2000).
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Figure 20: Example of an optical image of a ball bearing (passed) before wear testing

Expected contact area diameters were calculated for wear tracks created from
varying degrees of load on different substrates, stainless steel and titanium alloy.
Scratch tests were then performed, in a linearly increasing load from 1 to 15 N over
10 mm, with similar contact area diameters measured.
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Figure 21: 1 N end of 1 – 15 N scratch on stainless steel sample

Figure 22: Middle of 1 – 15 N scratch on stainless steel
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Figure 23: 15 N end of 1 – 15 N scratch on stainless steel

Figure 24: I N end of 1 – 15 N scratch on SP5C sample
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Figure 25: 15 N end of 1 – 15 N scratch on SP5C sample

From these images it was determined that the optimal load required for future wear
testing would be at 10 N due to a change in damage coverage in the CoBlast™
modified samples.

Wear testing was then performed on 10 mm x 10 mm x 1 mm square samples at 10
N force for 1, 10, 50, or 100 cycles at 10 mm in length with a 3 mm WC ball bearing,
some shown in Figure 26.

Figure 26: 3 mm WC ball bearings used in wear testing
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These samples consisted of SB, SP5C, SP9C, TB, TP5C, and TP9C. Optical images of
the stainless steel samples are presented below in Figure 27. Additional images can
be found in Appendix A.

Figure 27: Optical images of wear tracks on stainless steel samples.

Coefficient of Friction
During wear testing, the CETR UMT system records various parameters such as
time, velocity, the force in the x and z directions, and coefficient of friction (COF).
Analyzing the COF allows us to see changes in how the surface is interacting with
the WC ball bearing, which in turn can correspond to the wear the material is
experiencing. Analysis of the average COF was both done by hand for the 1 and 416
pass tests and others done using a MATLAB code developed by J. Maier and M.
Kennedy, which can be found in Appendix B. The COF experienced during constant
velocity during each pass was averaged and graphed, as seen in Figure 28.
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Figure 28: Average coefficient of friction by pass during constant velocity during 50 pass wear test
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The COF values were all consistently different during a pass to the right versus a
pass to the left, making the graphs appear jagged. To smooth the graphs and get a
better understanding of how the material was interacting during each cycle, the left
and right pass for each cycle was averaged and the data was graphed again, as seen
in Figure 29.

Figure 29: Average coefficient of friction by cycle during constant velocity during 50 pass wear test

From this initial examination of the coefficient of friction seen during a 50 pass test,
it can be seen that the base, unmodified titanium alloy sample experienced the
highest COF. This was as expected with the poor wear properties that titanium alloy
exhibits. It should be noted that with the P5C and P9C CoBlast™ modification, the
coefficient of friction was successfully reduced significantly. The stainless steel
unmodified sample initially was similar to the CoBlast™ modified samples, however
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after about 13 cycles, it begins to increase and steadily does so to the end of the test.
This increase in COF shows the instability of the surface of the stainless steel
samples, which could be due to the manufacturing process altering the surface
compared to the underlying base material. The wear test was then increased to 100
passes long, and this just further showed the increase in COF seen in the unmodified
stainless steel sample, as seen in Figure 30 by pass and then again smoothed in
Figure 31.

Figure 30: Average coefficient of friction by pass during constant velocity during 100 pass wear test
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Figure 31: Average coefficient of friction by cycle during constant velocity during 100 pass wear test
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The slight increase in COF values at the end of the 100 pass test seen in SP5C was of
interest, so another wear test of 416 passes was performed. A portion of the data
from the SP5C and all of the data from the SP9C testing was corrupted and could not
be used for analysis. The results from the titanium alloy-based samples can be seen
below in Figure 32 and Figure 33.

Figure 32: Average coefficient of friction by pass during constant velocity during 416 pass wear test
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Figure 33: Average coefficient of friction by cycle during constant velocity during 416 pass wear test

It can be seen that through 416 passes of wear on the titanium alloy-based samples,
the COF was maintained at a significantly lower value than the unmodified titanium
alloy sample. It is unclear why there are significant deviations in the COF in the
samples, particularly the unmodified titanium alloy but also the TP9C sample,
however it is possible that there was a build-up of particles during testing that
increased the COF.

SEM Energy-Dispersive X-Ray Spectroscopy
In order to confirm and examine the depth of the damage done to the CoBlast™
modified samples from contact with the WC ball bearing during wear testing,
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energy-dispersive X-ray spectroscopy (EDS) was used. As presented in prior work
by ENBIO [83], the CoBlast™ modifications showed a heterogeneous distribution of
chemical composition, consisting of the different parameters used in the CoBlast™
production. This can be seen visually in EDS maps created by graduate student
Golnaz Tomaraei to show the distribution of different elements on the surface of a
TP9C sample. The maps for titanium (Ti) and vanadium (V) are superimposed on
the SEM image as seen in Figure 34. Since these elements exist in the substrate
alloy, the maps show that in some areas their signal cannot get out of the surface.

Figure 34: Elemental superimposed x-ray maps for titanium and vanadium

The elemental composition outside the wear track on the as-received portion of the
surface and within the wear track on titanium alloy samples that were subjected to
the 416 pass wear test were compared for differences. Images of TP5C and TP9C
and the examined regions of interest can be seen in Figure 35 and Figure 36,
respectively.
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Figure 35: Scanning electron microscopy image of 416 pass wear track on TP5C showing regions of
interest for energy-dispersive X-ray spectroscopy analysis
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The elements detected in “Spectrum 5” region of interest, or the area located in the
unworn area of the sample, can be seen in Figure 36 and those in “Spectrum 6”
region of interest, or the area located in the wear track, can be seen in Figure 37.

Figure 36: Elemental composition inside the region of interest called Spectrum 5 in Figure 35
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Figure 37: Elemental composition inside the region of interest called Spectrum 5 in Figure 35

The weight percentages of different elements determined in EDS can be used to
determine if the modification layer is still present after a wear test. Unfortunately, if
there are elements present in both the base substrate and the modified layer, like
aluminum which is present in both the titanium alloy Ti-6Al-4V and the CoBlast™
modification layer due to the alumina (Al2O3) abrasive component. However, the
decrease in weight percentage of fluorine in the wear track when compared to the
unworn area indicates less of the PTFE from the CoBlast™ modification process is
present in this worn area. This shows a possible breach in the CoBlast™ layer
through to the base material, however the minimal presence of vanadium could
indicate that the wear track did not successfully full break through this modification
layer.
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EDS was also performed on TP9C and the regions of interest included “Spectrum 3,”
or the as-received layer, and “Spectrum 4,” the region within the wear track.
Elemental analysis and weight percentages can be seen Figure 39 and Figure 40.

Figure 38: Scanning electron microscopy image of 416 pass wear track on TP9C showing regions of
interest for energy-dispersive X-ray spectroscopy analysis
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Figure 39: Elemental composition inside the region of interest called Spectrum 3 in Figure 38

Figure 40: Elemental composition inside the region of interest called Spectrum 4 in Figure 38

TP9C showed similar shifts in weight percentage of fluorine, with more being
present in the unworn area where the CoBlast™ modification was expected to be
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present. In addition, there was an increase in the weight percentage of titanium that
showed in the wear track area, indicating more of the base material was visible.
There was also a small but present increase in vanadium present in the wear track
area of interest.

Overall, EDS confirmed some removal of the CoBlast™ modification layer after 416
pass wear tests as predicted, however it was found that due to the lack of
homogeneity across the CoBlast™ layer, there were sections of the CoBlast™ layer in
wear tracks from fewer pass tests that was removed and the base substrate was
exposed. A further examination in what this wear track and modification layer
looked like was needed, so cross sectional images were created.

Wear Track Measurements: Attempted Methods
There were several techniques used to measure the width and depth of the wear
tracks formed after testing, each with limitations. Each of these are presented in
detail in Appendix A. First the Wyko Optical profilometer was used, however the
field of view became too small once wear tracks got wider from higher pass testing,
and without an automatic stage there was no way to keep track of where on the
wear track measurements were being taken. In addition, without the entire wear
track in view, the profilometer could not establish a baseline for the sample and
therefore measurements of depth were not accurate. Next the Olympus LEXT
profilometer was used since it has an automatic stage and newer technology to
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measure the track widths and especially depths. Although this technique proved to
be much better than the Wyko analysis, it was still unclear where the track widths
began and ended and it was impossible to know if the wear track was successfully
breaking through the CoBlast™ modified layer. The use of scanning electron
microscopy (SEM) would provide an aerial image similar to what could be seen with
the interferometers, however would not provide a calculated cross sectional view as
the LEXT could do. The advantage to the SEM however is the ability to perform
energy-dispersive

X-ray

spectroscopy

(EDS)

and

evaluate

the

elemental

composition of the materials to determine if the ball bearing had successfully worn
through the CoBlast™ layer. Unfortunately, it was very difficult to determine the
edges of the wear track, especially when needing to decrease the magnification to be
able to see the entire wear track width in one viewing so this technique was too
abandoned. EDS analysis was still done on the wear tracks to confirm that the
CoBlast™ layer was breached, as shown in a later section in this aim. To determine
the width and depths of the wear tracks, ultimately cross sectional analysis of the
wear tracks was done. The hesitation with this technique was that it is destructive
to the samples since they are potted in resin, however it provided very accurate
visuals to measure the wear tracks.

Wear Track Measurements: Cross Sectional Analysis
Three titanium alloy (Ti-6Al-4V) larger samples (2.54 cm x 2.54 cm) and three
stainless steel larger samples (2.54 cm x 2.54 cm) were obtained, each with the
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following varying surface modifications: one left unmodified, one CoBlast™ modified
with 50 µm alumina with PTFE, and one CoBlast™ modified with 90 µm alumina
with PTFE. The wear testing previously described with a 3 mm WC ball bearing
moving 10 mm at 0.067 mm/s with 10 N of force was performed for 1, 10, 50, 100,
and 200 passes. These square samples were then cut perpendicularly to the wear
tracks using a precision diamond and abrasive wheel saw and embedded in a clear
epoxy resin using EpoHeat CLR Epoxy Resin and Epoxy Hardener (Buehler). They
were then ground and polished using a grinder-polisher (EcoMet 3 with Automet 2
Power Head Polisher, Buehler), as seen in Figure 41.

Figure 41: A square sample cut in half and potted in epoxy resin, after grinding and polishing

Material analysis was conducted using an optical microscope (Huvitz, HRM-300),
where wear track width, depth and CoBlast™ thickness were measured and
recorded, as seen in Figure 42.
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Figure 42: Cross sectional images of CoBlast™ modification used to calculate the number of passes
needed to break through modification layer (white section is the base material, gray section is the resin,
darkest layer is CoBlast™ modification. Red marks were used for identification purposes and are not
relevant to the sample.)

It was then calculated that it would take 347 passes to break through the CoBlast™
layer and 415 passes in a worst-case scenario for the ball bearing to sufficiently
break through the CoBlast™ layer, so a subsequent 416 pass test was performed and
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this cross sectional analysis was repeated. Some of these images can be seen in
Figure 43 however more can be found in Appendix C.

Figure 43: Optical microscopy images and measurements of various wear tracks (white section is the
base material, gray section is the resin, darkest layer is CoBlast™ modification. Red marks were used for
identification purposes and are not relevant to the sample.)

The wear tracks for the 100, 200, and 416 pass wear tests were measured in width
and depth using the optical microscope (Huvitz, HRM-300) using the Panasis
imaging program. Results from these measurements can be found in Table 11 and
Table 12.
Table 11: Track width of all 2.54 x 2.54 square samples used in wear testing

Track
Width

100 Passes
(µm)

200 Passes
(µm)
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416 Passes
(µm)

SB
SP5C
SP9C

239.94
216.40
207.57

259.47
250.42
245.61

372.67
294.08
n/a

TB
TP5C
TP9C

235.31
215.03
220.32

243.13
226.45
254.52

387.02
253.82
317.54

Table 12: Track depth of all 2.54 x 2.54 square samples used in wear testing

Track
Depth
SB
SP5C
SP9C

100 Passes
(µm)
7.37
2.64
3.99

200 Passes
(µm)
8.04
3.49
4.71

416 Passes
(µm)
11.73
6.99
n/a

TB
TP5C
TP9C

4.29
3.64
2.73

7.29
2.05
6.77

19.13
6.92
8.20

The cross sectional measurements of the increasing wear tracks showed a general,
expected trend that with an increase in the number of passes, there was an increase
in track width and depth. This was only not true for the TP5C sample depth
comparing the 100 to 200 pass tracks. This could be due to where the track was cut
in preparation for the resin potting, error in identifying the edges of the track, or a
particulate interference in the 100 pass test to make it falsely deep. The biggest
thing to note from Table 11 and Table 12 is that the CoBlast™ modification,
regardless of the alumina particle size, decreased the effect of the wear test on the
sample. First examining the stainless steel-based samples, for the 100 pass test,
SP5C experienced a 9.42% decrease in width and a 64.18% decrease in depth
compared to the stainless steel blank sample. SP9C experienced a 13.49% decrease
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in width and a 7.35% decrease in depth. Looking at the 200 pass test, SP5C
experienced a decrease in track width by 3.49% and depth by 56.86% and SP9C
experienced a track width decrease by 5.34% and depth decrease by 41.42%. When
put through near failure with the 416 pass test, SP5C still had shown a decrease in
track width by 21.09% and depth by 67.81%. The CETR failed during SP9C 416 pass
wear testing and could not be calculated accurately. These results showed that
CoBlast™ surface modification was effective in protecting the stainless steel base
substrate up until its failure at 416 passes of wear testing. There was no significant
difference found between the protection provided by the 50 µm alumina treatment
compared to the 90 µm alumina CoBlast™ treatment. Examining the titanium alloybased samples, for the 100 pass test, TP5C experienced an 8.62% decrease in width
and a 15.15% decrease in depth compared to the titanium alloy blank sample. TP9C
experienced a 6.37% decrease in width and a 36.36% decrease in depth. Looking at
the 200 pass test, TP5C experienced a decrease in track width by 6.86% and depth
by 71.88% and TP9C experienced a track width increase by 4.68% and depth
decrease by 7.13%. When put through near failure with the 416 pass test, TP5C still
had shown a decrease in track width by 34.42% and depth by 63.83% and TP9C
showed a track width decrease by 17.95% and depth decrease by 57.14%. These
results showed that the CoBlast™ modification significantly protected the base
substrate from wear, especially the higher the number of passes experienced, up
until failure which began to occur at 416 passes.
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Discussion: Wear analysis
Coefficient of friction data showed that the CoBlast™ modifications protect the base
materials, both stainless steel and titanium alloy, from experiencing the same
interactions with the ball bearing. Stainless steel initially had a similar COF to the
CoBlast™ modified materials, however consistently increased in COF after a few
cycles of wear testing. These results indicate a possible improved wear resistance
provided by the CoBlast™ modification technique, however coefficient of friction
does not always perfectly indicate the wear performance of a material, so wear track
width and depth analysis was performed.

EDS analysis of the SEM images taken of the titanium alloy samples modified with
the CoBlast™ layer using alumina with PTFE yielded an insight into the elements
exposed to the surface both in the unworn area of the sample and within the 416
pass wear track. As a result of the incomplete stainless steel testing due to machine
malfunction, the stainless steel samples were not evaluated via this method. For
both TP5C and TP9C, the area within the wear track showed a decrease in the
weight percentage of fluorine, which is present abundantly in the CoBlast™ layer
due to the PTFE used as a dopant in that process. In addition, TP9C showed an
increase in titanium alloy within the wear track, indicating the base material was
showing more than when the full CoBlast™ layer was on it. Since fluorine was still
present in the wear tracks of both TP5C and TP9C, it cannot be concluded that the
CoBlast™ layer was completely removed from the 416 pass wear test, however it is
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unclear as to how much of the CoBlast™ layer was still present in the wear track as
well as if the presence of the fluorine was more a result of the heterogeneity of the
modification layer as previously discussed, so a cross-sectional view was analyzed.

Several methods were used in an attempt to determine the wear track widths and
depths throughout this study and discussed in more detail in Appendix A. Initially,
profiling the wear track with an optical profilometer was attempted because the
Wyko NT-2000 system is capable of forming an X-Y profile of a sample it is
analyzing. However, we found that with an increase in the number of passes in the
wear test, the track width increased beyond the field of view of the system. When
comparing the initial results from the Wyko system with the Dektak contact
profilometer, we found that the stylus of the Dektak system at Clemson University
was too large for the small peaks and valleys of the CoBlast™ modified surface and
the contact profilometer had to be abandoned. Attempting a third profilometer
brought in the use of the Olympus LEXT, which while promising, still yielded
questions of how accurately we could see where the edge of the track truly began
and ended. For a closer look, the samples were analyzed with SEM, however there
was no way to truly determine the depth of these wear tracks. After weighing the
pros and cons of these methods, we determined it was worth permanently
damaging the samples to get a definitive measurement on the track widths and
depths and so they were cut perpendicularly, potted in resin, and analyzed under
optical microscope.
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The cross sectional view allowed us to examine the true shape of each wear track,
however only at one location—the location of the perpendicular cut. Therefore, a
limitation to this method is that we do not know if the location of the cross sectional
cut is truly indicative of the shape of the rest of the track. Assuming the track is
relatively uniform however, we were able to measure and compare both the track
width and depth for each wear test, with the exception of the final 416 wear test on
SP9C, at which time the CETR machine malfunctioned. From these track width and
depth measurements we are able to see the significant wear benefits of the CoBlast™
surface modification technique. As the number of passes increased in the wear
testing, the track width and depth increased for all samples, with the exception of
the depth of TP5C from 100 to 200 passes. This one exception could be due to the
location of the perpendicular cut not being an accurate portrayal of the majority of
the track, from the edge of the track being difficult to identify due to the nonhomogeneous nature of the CoBlast™ layer, or from a particulate getting in the track
during the 100 pass wear test, making this track falsely deep. At any rate, the trend
for all other samples was that as the number of passes in the wear test increased,
the track width and depth increased. It was also found that the CoBlast™
modification yielded a smaller width and depth than the unmodified sample on
every wear test performed, with the exception of the 200 pass test on TP9C, possibly
for similar reasons listed previously. This wear protection was provided up until
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416 passes, where the CoBlast™ layer was nearly completely removed in the wear
track (due to its non-homogenous nature, some sections were still present).

Titanium is known for its poor wear resistance, often failing due to adhesive wear
where the contacting material welds to the titanium material and creates a rupture
strength higher than the strength of the material [84, 85]. The addition of alumina
via the CoBlast™ process introduces a ceramic to the surface. Ceramics are known
for their extreme hardness, which in turn often translates to good wear resistance
[86]. This layer of ceramic provides a level of wear resistant protection before the
contacting ball bearing comes in contact with the base material.

Wettability
Wettability tests were done on the samples previously mentioned in the surface
roughness analysis where 5 samples of each possible modification variety were
measured in 6 locations, as seen in Figure 15. The (n=30) results are shown graphed
in Figure 16 for reference. The wettability tests were split into four: contact angle
analysis with or without fouling the surface of the samples with albumin to more
closely mimic the interaction of the surfaces in the human body, using deionized
water or diiodomethane (commonly referred to as methylene iodide, MI). 1-2 µl of
liquid was dropped using a goniometer (KRUSS EasyDrop) and analyzed using the
KRUSS Drop Shape Analysis software for contact angles formed. The contact angle of
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the drop of liquid, as seen in Figure 44, is measured on the left and right side of the
droplet and averaged to yield the mean contact angle.

Figure 44: Example image of sessile drop technique, where the two angles between the material and the
liquid are measured and >90 degrees indicates hydrophobicity

Each sample was tested at two locations, as in Figure 45, for a total of 10 data points
for each treatment type.

Figure 45: Wettability contact angle testing locations

-

Contact angle testing without protein fouling
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Wettability testing was first done on samples as received using 2 µl of water. The
average contact angles measured with the goniometer were recorded in Table 13
and Table 14 and then graphed as in Figure 46.
Table 13: Average contact angles on stainless steel samples found using the sessile drop technique with
deionized water

Sample
SB
SBX
SBV
SP5C
SP5CX
SP5CV
SP9C
SP9CX
SP9CV
SA5C
SA5CV
SA9C
SA9CV

Average
Angle
63.50
83.73
76.21
124.33
108.00
104.25
124.89
111.35
109.21
84.86
90.10
112.53
84.16

St. Dev.
7.50
3.63
4.84
2.11
8.71
7.32
2.87
10.88
9.90
7.93
4.83
4.59
4.54

Table 14: Average contact angles on titanium alloy samples found using the sessile drop technique with
deionized water

Sample
TB
TBX
TBV
TP5C
TP5CX
TP5CV
TP9C
TP9CX
TP9CV
TA5C
TA5CV

Average
Angle
59.74
81.16
79.22
127.14
106.43
95.87
130.07
115.35
107.12
77.24
85.59

St. Dev.
13.14
2.18
7.75
2.01
5.28
6.18
2.66
9.95
8.71
8.46
6.19
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TA9C
TA9CV

81.93
91.64

10.59
5.20

Figure 46: Average contact angles found for each of the sample types when tested with deionized water.

When comparing the same coatings with different bases using a t-test, the majority
of the samples were not significantly different. The samples with significant
differences were P5C, P9C, A9C, and A9CV, with A9C having the most significant
difference, and A9CV having the least. Further statistical analysis was done on
samples with the titanium alloy base, as this would be the base material of the
implant used in the future animal study, to be discussed later in the document. Most
of these comparisons were found to have statistically significant differences, as seen
in Figure 47.
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Figure 47: Average contact angles of titanium alloy-based samples with statistical significance denoted

Wettability testing was then done on samples as received using 1 µl of MI. This
change in quantity of liquid used in the drop testing was due to the viscosity of the
liquid. The average contact angles measured with the goniometer were recorded in
Table 15 and Table 16 and then graphed as in Figure 48.
Table 15: Average contact angles on stainless steel samples found using the sessile drop technique with
diiodomethane

Sample
SB
SBX
SBV
SP5C
SP5CX
SP5CV
SP9C
SP9CX
SP9CV
SA5C
SA5CV

Average
Angle
38.51
41.39
41.43
75.39
62.19
60.16
114.52
89.84
96.11
37.09
44.55

St. Dev.
6.20
1.80
1.13
10.09
9.89
3.33
3.53
9.91
8.19
5.04
3.10
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SA9C
SA9CV

39.76
44.23

4.52
4.04

Table 16: Average contact angles on titanium alloy samples found using the sessile drop technique with
diiodomethane

Sample
TB
TBX
TBV
TP5C
TP5CX
TP5CV
TP9C
TP9CX
TP9CV
TA5C
TA5CV
TA9C
TA9CV

Average
Angle
43.16
40.78
41.47
79.55
57.3
46.53
114.89
70.96
74.79
36.11
44.5
38.39
47.47

St. Dev.
8.02
2.86
1.17
7.24
7.36
4.22
5.43
5.85
11.26
6.05
2.55
5.12
5.90
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Figure 48: Average contact angles of samples tested with diiodomethane without protein fouling

When comparing the same coating on different base substrates, the only samples
with statistically significant differences were P5CV, P9CX, and P9CV, with P5CV
having the most significant difference, and P9CV having the least.
-

Contact angle testing with protein fouling

Protein fouling the surface of the samples was of interest to better mimic how these
materials would interact in the body. Albumin was chosen as the protein to foul the
surfaces because as mentioned previously, albumin is the most abundant protein in
human blood plasma. 10 mg/ml human serum albumin (Alfa Aesar Human Albumin
96%, lyophilized powder) was used to protein foul the surface of the samples. Five
samples per treatment group were used, with testing performed on 2 locations per
sample. Samples were placed in a 24-well plate with 800 µm of phosphate-buffered
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saline (PBS) (pH 7.4) covering them. 200 µl of an albumin-PBS solution of the
concentration previously indicated was added to each well and left for 2 to 24 hours.
The samples were then flushed with distilled water 6-8 times and placed in sterile
well plates to dry. Results from testing with DI water can be seen in Table 17 and
with MI can be seen in Table 18.
Table 17: Average contact angle of deionized water on samples fouled with human serum albumin
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Table 18: Average contact angle of diiodomethane on samples fouled with human serum albumin

This contact angle testing with DI water showed that blank and PTFE CoBlast™
modified samples without the BioDep™ process applied had higher contact angles,
yet the opposite was true for alumina-only CoBlast™ modified samples. This can be
seen in Figure 49.

72

Figure 49: Contact angle of deionized water on protein-fouled titanium alloy samples (Statistical
significances indicated: * = p<0.05, ** = p<0.01, 888 = p<0.001, **** = p<0.0001)

The blank samples all had similar contact angles with MI, with the only statistically
significant exception being between TBX and TBV. These can be seen in Figure 50.
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Figure 50: Contact angle of diiodomethane (MI) on protein-fouled titanium alloy samples (Statistical
significances indicated: * = p<0.05, ** = p<0.01, 888 = p<0.001, **** = p<0.0001)

The P5C and all alumina-only CoBlast™ modified samples had lower contact angles
when vancomycin was present on the surface than without it, yet the opposite
occurred with P9C samples. Overall, most of the same trends held true as the nonprotein fouled samples.

There were a few limitations and irregularities that arose during testing with the MI
liquid. One thing to note is that the TP5CX, TP5CV, TP9CX, and TP9CV all had large
standard deviations despite no change in protocol or any other change in procedure
or sample storage conditions. These samples were retested for consistency, but no
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significant change occurred. Additionally, there were limited samples for testing
TP9C, TA5CV, and TA9CV with protein-fouling so only 4 data points (as opposed to
the 10 for other sample types) were used in the data analysis of the contact angle for
protein-fouled samples with MI.

-

Surface energy without protein fouling

The data collected from the water and MI sessile drop testing, it was used to
calculated the surface energy of each of the treatment types. The following
equations were used:
3

𝛾"# = (𝛾& /4)(cos 𝜃 + 1)0 and (𝛾"# 𝛾&# )1/0 + (𝛾"2 𝛾& )1/0 = 𝛾& (cos 𝜃 + 1)/2
where 𝛾&# = 50.8 mN/m for diiodomethane, 𝛾&# = 26.4 mN/m for deionized water,
and 𝛾&2 = 46.4 mN/m for deionized water. The results from these calculations can
be found in Table 19 and Table 20 and are represented graphically in Figure 51.
Table 19: Surface energy for stainless steel samples, calculated using the contact angles from tests with
deionized water and diiodomethane

Sample
SB
SBX
SBV
SP5C
SP5CX
SP5CV
SP9C
SP9CX
SP9CV
SA5C
SA5CV

Surface
Energy
40.9869
39.4722
38.8962
25.2357
30.5922
31.0760
4.3471
12.9559
10.1570
42.0830
38.6162
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SA9C
SA9CV

50.3189
37.8709

Table 20: Surface energy for titanium alloy samples, calculated using the contact angles from tests with
deionized water and diiodomethane

Sample
TB
TBX
TBV
TP5C
TP5CX
TP5CV
TP9C
TP9CX
TP9CV
TA5C
TA5CV
TA9C
TA9CV

Surface
Energy
38.9052
39.3933
38.9389
20.6085
32.2783
37.6016
4.3121
24.3886
20.8205
41.6038
37.6253
40.7053
36.4528
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Figure 51: Surface energy calculated for samples without protein fouling

As before, the same treatment type on the different base substrates was compared
and only four showed statistically significant differences: P5CV, P9CX, P9CV, and
A9C. Of those, P9CV had the least significant difference, while P5CV had the most.
The lowest surface energy found were the P9C samples, both of which had the some
of the highest contact angles with both the deionized water and MI, leading to the
low surface energy calculations. All other samples had contact angles less than 90
degrees with MI, so the surface energy is higher.

-

Surface energy with protein fouling

Unlike the blank samples without protein fouling, there were statistically significant
differences between these sample types and many others. These significant
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differences included comparing the TB samples to the CoBlast™-only samples
(TA5C, TA9C, TP5C, TP9C) and the vancomycin-deposited samples. Similar to the
results from the testing without protein fouling, the TP9C group had the lowest
surface energy, significantly lower than any other group.

Figure 52: Surface energies of protein fouled titanium alloy samples

Discussion: Wettability
From this contact angle testing, it can be confirmed that the presence of PTFE on the
surface yields a more hydrophobic surface than samples without this treatment, as
expected. Samples modified with the CoBlast™ technique without PTFE present
(alumina-only) were typically found to be hydrophilic. When comparing the data
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sets of contact angles that occurred between the samples and DI water, with and
without protein fouling, it was found that there was a significant difference between
the values, with the exception of TP9C and TP9CV. This significant effect of protein
fouling on the contact angles experienced were not seen when using MI. Only TBV,
TA5C, TP5C, and TP9C showed a significant difference (p<0.05), so there was no
conclusion made that the protein fouling samples before contacting them with MI
significantly affected the overall wettability of the samples.

Protein fouling with albumin to simulate the environment more likely found in the
human body, the surfaces were found to be generally more hydrophilic than before,
however statistical analysis between the surface energy of groups subjected to
protein fouling and those not found that most showed significant differences. The
only sample with a significant difference in surface energy that also had vancomycin
deposited on it was TBV, whereas all other samples with vancomycin treatments
showed no statistically significant differences.

Overall, consistently the TA5C- and TA9C-based samples proved to be the most
hydrophilic CoBlast™ treatment and since hydrophilic materials have been shown to
be more resistant to the adherence of S. aureus, it was concluded that these
materials should be considered for antimicrobial applications over materials treated
with the CoBlast™ modification using PTFE. There was no significant difference
between the benefit of the samples without CoBlast™ modifications and those with
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the alumina-only CoBlast™ modifications, so it was recommended to not exclude
either group from future analysis in vivo.

Discussion
Individual discussions of the results from each section of the material
characterization provided more detailed conclusions from these studies, however
the collective work done examining the properties of the surfaces subjected to the
CoBlast™ modification process led to general recommendations for the rest of the
study as well future applications of this modification technique. Surface roughness
analysis showed that the particle size of the abrasive used in the CoBlast™
modification process directly changed the surface roughness of the materials.
Regardless of the base material, the 50 µm alumina abrasive yielded a rougher
surface than the original base materials, and this roughness further increased with
the use of the 90 µm abrasive particles. The presence of chitosan or chitosan with
vancomycin from the BioDep™ process did not affect the surface roughness of the
base materials, regardless if the CoBlast™ layer was present underneath the
BioDep™ layer. Since an increase in surface roughness indicates an increase in the
area of the surface, it was recommended that 50 µm abrasive particles be used in
biofilm prevention therapies using CoBlast™. This increase in surface roughness
from the CoBlast™ process also indicated the CoBlast™ treatment may not be as
ideal as a polished traditional implant for biofilm prevention, as it would be easier
for the bacteria to adhere. These conclusions were made solely from the surface
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roughness results and were further assessed after examining further analysis
techniques.

To determine how the CoBlast™ application would fare under high-wear conditions
for the possible recommendation of future applications other than use on DCPs,
wear testing was performed on samples with the P5C and P9C CoBlast™
modifications. The P5C consistently produced a smaller wear track in comparison to
P9C in identical testing, however with only one sample for each treatment group, it
is unclear if this trend is statistically significant. Overall, it was determined that the
CoBlast™ modification improved the wear resistance of the materials, regardless of
if the base material was stainless steel or titanium alloy. CoBlast™ would be
recommended as a modification to a metal surface that needed improved wear
resistance, particularly for a titanium alloy base material that exhibits poor wear
properties in its unaltered state.

Wettability testing examined the interactions of DI water and MI with the treated
and untreated surfaces with and without the presence of the protein albumin on the
surface of the material. PTFE present in the CoBlast™ modification layer increased
the hydrophobicity of the surface, regardless if a BioDep™ coating was added, so the
use of PTFE in the CoBlast™ process in an application looking to prevent bacterial
adhesion would be undesirable. In particular, the titanium alloy samples without
any form of CoBlast™ surface modification as well as titanium alloy samples with
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alumina-only CoBlast™ modifications were found to be the most desirable
treatments for applications that looked to deter the adherence of bacteria such as S.
aureus due to the increased hydrophilicity.

From these findings, the following recommendations were made: 1) for an
application desiring improved wear resistance, the CoBlast™ modification process
would be a recommended treatment, 2) CoBlast™ modifications using 90 µm
abrasive particles would not be recommended for an application desiring a decrease
in bacterial adhesion due to the increased surface area, 3) to deter bacteria attracted
to hydrophobic materials, it would not be recommended to modify the surface with
CoBlast™ using the dopant PTFE. Samples were then examined interacting with the
bacteria S. aureus to determine the effects of the treatments in vitro, presented in
the following chapter, for a future application intending to prevent bacterial
adhesion.
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CHAPTER FOUR
IN VITRO ANALSYSIS OF THE BIODEP™ MODIFICATION

Background
To translate how the CoBlast™ and BioDep™ surface modification techniques could
be useful in inhibiting biofilm formation on the surface of treated implants, an in
vitro analysis of the bacterial inhibition of these surface modifications was
performed.

Bacteria and Biofilms
Infection has long been a major problem in orthopaedics and surgery and can lead
to implant failure and replacement, amputation, and occasionally mortality [87].
Bacteria can enter the site via contaminated surgical equipment, the operating
room, the operating staff, or bacteria already present on the patient’s skin [88].
Additionally, in severe orthopaedic trauma bacteria is often introduced via dirt and
debris that enter an open wound.

Approximately four out of every five implant-related infections are caused by
staphylococci [89]. Most commonly, Staphylococcus aureus and Staphylococcus
epidermidis are capable of forming biofilms and are responsible for infection in
orthopaedics [89]. Staphylococcus is a genus of Gram-positive bacteria 0.5-1.5 µm in
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size [78]. These bacteria are spherical and when they divide they form grape-like
clusters, as seen in Figure 53.

Figure 53: Grape-like clusters of Staphylococcus
(https://www.sciencedaily.com/releases/2016/05/160516181030.htm)

S. aureus is a pathogen commonly found on the skin and the anterior nares of
humans without cause for concern, however once the bacteria breaches the
cutaneous or mucous barriers, serious infections can develop [39]. Nosocomial
infections caused by S. aureus are common in the presence of implanted medical
devices [78, 90, 91, 92]. Treating infections caused by S. aureus can be complex due
to antibiotic resistant strains, including methicillin-resistant S. aureus (MRSA) [39].
Aside from antibiotic resistance, S. aureus uses adhesins called microbial surface
components recognizing adhesive matrix molecules (MSCRAMMs) that interact with
extracellular matrix (ECM) components to bind to bone matrix. These MSCRAMMs
include binding proteins for fibronectin, fibrinogen, elastin, and collagen [39]. They
are necessary for the adhesion of the bacteria to biomaterials and are directly
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involved in early colonization, and invasion of bacteria [78, 93, 94]. Upon
implantation of a biomaterial, the host responds with coating the material with
serum proteins to promote tissue repair, however these proteins are also used by
invading pathogens for adhesion and virulence [95, 96, 97]. This “race to the
surface,” originally suggested by Gristina, can lead to the formation of biofilms on
the hardware [98].

Freely moving bacteria, or planktonic bacterial cells, prefer to grow on a surface as
opposed to continue floating in the aqueous phase [99, 100]. Once the bacteria and
any extracellular materials collect on a solid surface, the biomass can be called a
biofilm [23]. Generally biofilm attachment occurs in five major steps: 1) the surface
gains a conditioning layer, acting as a foundation for bacteria to anchor and get
nutrients, and can consist of anything present in the surrounding fluid, inorganic or
organic [101]; 2) a reversible attachment phase where bacteria is attracted to a
material via physical, long-range and short-range interactions like Brownian motion
and van der Waals forces [102, 103]; 3) an irreversible attachment phase in which
the appendages overcome any repulsive forces, allowing permanent adhesion to be
achieved [104]; 4) a growth phase, where in the right environmental conditions any
stationary cells that are attached to the material surface begin to divide, creating a
protective mushroom-like structure with pathways for nutrients [105]; and 5) final
stages which include a stationary phase where the rate of cell division is the same as
the rate of cell death, followed by the death phase, where the cells in the biofilm
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make enzymes that destroy the polysaccharides that hold the community together
[101]. The environment surrounding the bacteria has a significant effect on the
health of the biofilm and its ability to adhere to a surface, including temperature,
amount of bacteria and its orientation, the presence of antibiotics, flow condition,
and the presence of a conditioning layer [23, 101, 24, 26].

In vitro Simulations
Implants and biomaterials are an optimal site of bacterial colonization due to their
lack of antiphagocytic reaction towards bacteria, allowing the bacteria to adhere,
colonize, and multiply easily on the surface [106]. To help, biomaterial modifications
can be made to minimize or prevent this adhesion, as discussed in the prior section
of this dissertation. One modification to note is the use of an antibiotic layer or
coating on the biomaterial surface to allow a local release of concentrated antibiotic.
BioDep™, the plasma deposition technique previously mentioned that allows for
chitosan and vancomycin to be deposited on the surface of a material, is such a
modification and the mechanism and release capabilities have only been minimally
investigated.

There are several methods to examine the elution of antibiotics from biomaterials,
including high-performance liquid chromatography (HPLC), antimicrobial dilution
tests such as finding the minimum inhibitory or bactericidal concentration (MIC and
MBC), and the Kirby-Bauer disk diffusion test. The Kirby-Bauer test is traditionally
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used to determine the susceptibility of certain bacteria to various antibiotics [107].
This test uses consistent amounts of Mueller-Hinton agar plates, spread with a
chosen bacteria strain, on which filter paper impregnated with known amounts of a
chosen antibiotic are placed and allowed to diffuse into the agar. As the bacteria
grow, the antibiotic interacts with them and diffuses, creating a zone of inhibition in
which bacteria will not grow. These zones can be measured in diameter and
compared to a standardized chart, similar to Figure 54, to determine the resistance
of the bacteria to the drug.
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Figure 54: Kirby-Bauer disk diffusion test results chart indicating the resistance of known antibiotics
[108]

Since BioDep™ involves a layer (or multiple) of a known antibiotic, the ability of the
antibiotic to release after this deposition process was of interest and a modification
of this Kirby-Bauer testing was performed to examine the zones of inhibition that
formed around the discs treated with the BioDep™ process.
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In vitro simulations can be very useful in testing various parameters of a
study setup to optimize a process, however they can never fully replicate what will
happen once the product or process is brought to a live body. In vivo testing, such as
animal models, have provided researchers with the ability to learn about the
efficacy of process and products in the body before releasing them to the human
population. It is a very important step in the translation of a device or development
from the laboratory to the patient because the in vitro susceptibility of a process can
vary from the in vivo efficacy due to live tissue reactions and interactions with the
foreign substance. The translation of this work to an in vivo model will be discussed
in the following section.

Research Outcomes
CoBlast™ and BioDep™ both have potential antimicrobial properties that should be
evaluated with various bacterial studies. The powder composition used in CoBlast™
can include PTFE which may have an effect on the likelihood of bacterial adherence,
and BioDep™ uses chitosan, which has shown occasionally in literature to have an
antimicrobial effect, and vancomycin, a common antibiotic that has been shown to
decrease the prevalence of infection. The BioDep™ process can deposit multiple
layers, therefore increasing the volume of substance it is depositing on the surface.
The traditional deposition of vancomycin includes a single layer deposited at 150V,
however strength of power as well as amount of layers can be varied to provide
different parameters to compare and evaluate. Primarily we wanted to determine
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the effect of multiple BioDep™ layers on bacterial inhibition, then determine the
effect of the various CoBlast™ parameters under the BioDep™ layer, and finally
determine the benefit of having a CoBlast™ layer under the BioDep™ layers.

Determining the effect of multiple BioDep™ layers
-

Materials and Methods

In analyzing the bacterial inhibition of the various surface modifications in vitro, two
hypotheses were formed: that the inhibition of bacterial growth would be greater
the more layers of vancomycin that were deposited using the BioDep™ deposition
process and that vancomycin deposited via the BioDep™ process would have a
stronger effect minimizing the bacterial growth than chitosan alone or the CoBlast™
treatment alone.

To explore this first hypothesis, a Kirby-Bauer zone of inhibition study was
performed on the samples. For this study, a sterile loop was used to collect colonies
of S. aureus and was cultured in 10 ml of tryptic soy broth (TSB) 18 hours prior to
the start. Using a sterile tube, the culture was diluted with sterile water to reach a
turbidity equivalent to the 0.5 McFarland test standard. At OD600 this was ~1.5x108
cells/ml. Within 15 minutes of diluting the culture, a sterile swab was dipped in the
properly adjusted inoculum. The side of the swab was pressed on the side of the
tube to eliminate any excess moisture. The entire Mueller-Hinton agar plate was
streaked with the swab, rotating 60 degrees each time (three total swabs). The lid of
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the plate was closed for 3-5 minutes to allow it to dry and then the 10 mm diameter
discs of interest were placed face down on the agar, using a sterile swab to push
down slightly. These discs had been treated with CoBlast™ or BioDep™ with various
parameters and triplicates were made of each. The plate was then placed in an
incubator at 37˚C. Plates were examined at 24 hours and the zones of inhibition
formed around the discs were measured in millimeters.

-

Results

The Kirby-Bauer method was first explored comparing TP5C, TP5CV, and TP5CV9
discs, as can be seen in Figure 55. More images of all zone of inhibition testing can
be found in Appendix D.

Figure 55: Zone of inhibition testing of TP5C, TP5CV, and TP5CV9
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Zones were measured by their diameter across the center of the disc. If no zone
formed around the disc the zone was not measured, however if there was a zone, it
is reported as the full diameter in millimeters, including the 10 mm diameter disc. In
this preliminary run there was no zone around TP5C, as expected since it does not
contain vancomycin, and a 15.69 mm zone for TP5CV and a 20.75 mm zone for
TP5CV9. This showed both that vancomycin is needed on the surface to inhibit the
bacteria around it and that CoBlast™ alone was not sufficient, but also that
increasing the number of BioDep™ layers seemed to increase the zone of inhibition
that formed around the sample.

Kirby-Bauer disc diffusion testing was done on more samples which can be seen in
Figure 56 and diameters in millimeters of zones of inhibition measured listed in
Table 21.

Figure 56: Zones of inhibition around samples confirming the need for the presence of vancomycin for
results as well as confirming that more layers of vancomycin indicate a larger zone of inhibition
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Table 21: Average zones of inhibition in millimeters from triplicate testing

TB
TA5C
TA9C
TP5C
TP9C
TBV
TA5CV
TA9CV
TP5CV
TP9CV
TP5CV3
TP5CV6
TP5CV9
TP5CV12
TP5CVHP

Average diameter
(mm)
0
0
0
0
0
18.54
19.88
17.85
18.54
17.62
19.97
20.64
21.12
22.41
21.87

SD
0.83
1.40
0.69
1.29
0.88
0.66
1.13
1.72
0.99
0.53

The hypothesis that zones of inhibition would only form around plates treated with
vancomycin was confirmed with testing CoBlast™-only treated samples and finding
no zone to form.
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Figure 57: Average diameters of the zones for the samples with vancomycin present

First, statistical analysis was performed to examine the difference in using the
BioDep™ deposition process on a blank titanium alloy sample as opposed to on top
of a CoBlast™ modified surface. It was found when comparing the TBV with TA5CV
(p=0.22), TA9CV (p=0.33), TP5CV (p=0.99), and TP9CV (0.26), none were
statistically significant. Statistical analysis was then done comparing the size of the
zones around the varying layers of vancomycin in the TP5CV samples. Using a t-test,
it was found that there was no significant difference between a single layer TP5CV
and the 3, 6, and 9 layer options, however there was a significantly larger zone
around the 12 layer and high power 9-layer option. Although not significant, the 12layer option showed a larger zone of inhibition in this test than the high power
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option, however it was noted that there was flaking of the BioDep™ coating due to
the high number of layers, and therefore it was not recommended for use in the
animal study for sake of future manufacturing issues. This ultimately led to the
decision to use the high power 9-layer BioDep™ treatment on the implants in the
animal study. Since there was no significant difference found between the blank
sample with BioDep™ deposition and CoBlast™ modified samples with BioDep™
deposition from this work, we chose to include one implant in the animal study that
had CoBlast™ modifications and one implant without this CoBlast™ treatment.
Therefore, the next decision to be made prior to the animal study was the
parameters of the CoBlast™ modified implant.

Determining the effect of CoBlast™ parameters under the BioDep™ layer
-

Materials and Methods

This Kirby-Bauer testing was repeated for two disc types, TA5CV and TA9CV, to see
if the CoBlast™ abrasive particle size affected the ability of the BioDep™ layer to
elute. Three TA5CV discs and three TA9CV discs were placed on a Mueller Hinton
agar plate prepared in the same manner as previously described. As before, a sterile
loop was used to collect colonies of S. aureus and was cultured in 10 ml of tryptic
soy broth (TSB) 18 hours prior to the start. Using a sterile tube, the culture was
diluted with sterile water to obtain a turbidity equivalent to the 0.5 McFarland test
standard. At OD600 this was ~1.5x108 cells/ml. Within 15 minutes of diluting the
culture, a sterile swab was dipped in the properly adjusted inoculum. The side of the
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swab was pressed on the side of the tube to eliminate any excess moisture. The
entire Mueller-Hinton agar plate was streaked with the swab, rotating 60 degrees
each time (three total swabs). The lid of the plate was closed for 3-5 minutes to
allow it to dry and then the 10 mm diameter discs of interest were placed face down
on the agar, using a sterile swab to push down slightly. Triplicates of both the
TA5CV and TA9CV samples were made. The plate was then placed in an incubator at
37˚C. Plates were examined at 24 hours and the zones of inhibition formed around
the discs were measured in millimeters.

-

Results

The zone diameters were measured across the centers of the discs and recorded in
Table 22.
Table 22: Zones of inhibition around TA5CV and TA9CV samples

1
TA5CV 2
3
1
TA9CV 2
3

Diameter
(mm)
19.37
19.63
20.84
17.05
15.75
17.2

Average
(mm)

SD

19.947

0.784

16.667

0.919

It was found using a t-test that the TA5CV created a statistically significantly larger
zone of inhibition surrounding the samples (p<0.05). This improved ability to allow
the same amount of vancomycin in the BioDep™ coating to release effectively helped
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lead to the decision to use the 50 µm alumina particle size in the CoBlast™
modification process instead of the 90 µm abrasive particle.

Figure 58: 24-hour time point showing zones of inhibition around TA5CV and TA9CV samples

Determining the benefit of CoBlast™ under BioDep™ layers
-

Materials and Methods

After it had been determined that TBVHP9 and TA5CVHP9 would be used in the
animal study, titanium implants from Narang Medical, Ltd. were coated with those
treatments and tested. To also examine elution rate and rate of effectiveness, these
implants were checked at 12, 24, 36, and 48 hours to see how the zones of inhibition
grew or sustained at various time points.
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-

Results

Both TBVHP9 and TA5CVHP9 treatments successfully created a zone of inhibition
around the implants, as seen in Figure 59.
Table 23: Measurements of the lengths of the zones of inhibition formed around the implants

TA5CVHP9

TBVHP9

1
2
3
1
2
3

Length
(mm)
43.32
44.7
42.72
44.07
44.47
43.34

Avg (mm)

SD

43.580

1.015

43.960

0.283

Table 24: Measurements of the widths of the zones of inhibition formed around the implants

Width
Avg (mm)
SD
(mm)
1
16.3
TA5CVHP9
2
18.71
17.013
1.476
3
16.03
1
17.02
TBVHP9
2
17.59
17.283
0.403
3
17.24
When examining the statistical significance of the differences between the zones of
these implants it was found that there was no significant difference in length
(p=0.60) or width (p=0.77).
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Figure 59: 24-hour time point showing zones of inhibition around TA5CVHP9 and TBVHP9 implants

Discussion
The high power, which also technically had 9 layers of BioDep™ deposited, was
chosen as the optimal treatment option for the BioDep™ samples because it was
statistically significantly better than the single, 3, 6, and 9 layer options. The
traditional 9-layer option showed promising results, however was not statistically
significantly better than the 6-layer option at inhibiting the bacteria. The zone of
inhibition size of the 12-layer option was statistically significantly superior to the
single, 3, 6, and 9-layer options, however due to flaking of the surface it was deemed
unacceptable for manufacturing and would not be a viable option for the animal
study or any future work in humans. This work showed that by increasing the layers
of vancomycin deposited via the BioDep™ process, there would be an increase in
bacteria inhibition, with a limit to the number of layers feasibly deposited due to
flaking of the deposited coating. It was also found that there was no significant
difference in the ability of the vancomycin to be released between unmodified and
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CoBlast™ modified samples, both when comparing TBV to TA5CV, TA9CV, TP5CV,
and TP9CV and when comparing TBVHP9 to TA5CVHP9. All of these findings
ultimately led to the decision to use both the unmodified titanium alloy sample and
CoBlast™ modified base materials under the high power 9-layer BioDep™ deposition
in the animal study that followed this in vitro work.

It should be noted that the second hypothesis presented in the introduction to these
results, that vancomycin deposited via the BioDep™ process would have a stronger
effect minimizing the bacterial growth than chitosan alone or the CoBlast™
treatment alone, was explored by a colleague, graduate student Shayesteh Beladi.
Similar to the findings in this disc diffusion testing, there were no signs of bacterial
inhibition from the CoBlast™ treatment or BioDep™ treatment with chitosan alone,
although it should be noted that this was as expected for the Kirby-Bauer testing as
this test is intended to measure the efficacy of an antibiotic in preventing the
advancement of bacteria.

100

CHAPTER FIVE:
ANIMAL MODEL FOR ORTHOPAEDIC TRAUMA INFECTION

Background
Various methods of delivering antibiotics locally in orthopaedic trauma scenarios
have been researched and tested through animal models. Factors to consider when
choosing an animal model include the expense, mortality rate of the species, and
ensuring a comparable immunological and pathological pattern to humans [109].
Common animals for research in implant-associated infections include mice [110,
111], rats [112], guinea pigs [113], and rabbits [114, 115]. Larger animals often
more accurately imitate the human body and can better tolerate surgeries, however
they tend to be costlier and require large housing [115]. Rabbits are a good choice
for an orthopaedic infection model also examining bone healing due to their
sufficiently large femur yet them remaining a reasonably small animal, in addition to
them being easier to infect than dogs and rats in a reproducible manner [116]. Some
cons to the use of rabbits is that there is a need for a high inoculum of bacteria and
that they have high susceptibility to fractures post-implantation and therefore there
is a need for advanced surgical skills [109, 114].

In addition, the selection of inoculum and delivery method is important in the
development of an accurate animal model for orthopaedic infection. The species of
bacteria should reflect what is seen clinically, and since most open fracture
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infections are caused by Staphylococcus aureus, this is the common bacteria used in
these models and was chosen for this study [109, 22]. There are three main methods
of inoculation: pre-colonization of the bacteria on the implant in vitro prior to
implantation, direct inoculation at the implant site, or inoculating the bloodstream
[117]. As it is important to reflect what would be seen clinically and this study is
examining the effect of the CoBlast™ and BioDep™ processes on biofilm prevention
post-internal fracture fixation after an open fracture often seen in the battlefield,
direct inoculation at the implant site was used to mimic debris entering the wound.

There has been a lot of research done examining diagnostic, prophylactic, and
therapeutic measures for treating osteomyelitis, especially with S. aureus as the
causative pathogen. ATC 25923 (Seattle 1945 strain used in this research), ATCC
29213, and ATCC 49230 are all common strains of S. aureus used in animal
experimental models [118]. Internal fixation osteomyelitis models were first based
off the rabbit tibial model introduced by Schemen, later modified by Norden [119,
120]. The introduction of a foreign body such as a metallic implant was introduced
by Andriole et al. in which the tibia was fractured using a clamp and a stainless steel
pin was used for fixation [121].

In the model by Andriole et al. they were interested in developing a model that
created a chronic infection without the animals clearing the infection or dying from
it. In this study New Zealand white rabbits were injected with one of two different
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strains of S. aureus, one being penicillin resistant. The rabbits were then split into
four groups: 1 receiving an inoculation dosage only, 2 receiving inoculation after the
fracture of the tibia and fixation via a stainless steel pin, 3 receiving the inoculation
and stainless steel pin but no fracture, and 4 being controls, including three rabbits
given a fracture with an intramedullary rod without inoculation and one receiving
the rod without fracture or inoculation. During the time period 6 weeks to 18
months post-op a fragment of soft tissue and bone were collected and cultured to
examine and quantify the bacterial growth. This study showed they were able to
create a chronic staphylococcal osteomyelitis model in the rabbit tibia with a
metallic implant to closely mimic patients treated with intramedullary nails.

Not all models include a fracture in monitoring infection responses, such as in works
by Moriarty and Arens et al. [122, 123]. Arens et al. used a 6-hole dynamic
compression plate (DCP) for fixation on the tibia without fracture and with only
unicortical screws. Although femurs are also used in these studies, tibias are more
dominant in studies examining open fractures. In open fracture studies, the original
model used by Ashhurst et al. used a saw to create the fracture and plates were
implanted for stabilization [124]. Worlock modified this model to work for an
intramedullary rod and worked to determine the minimal dose needed to
consistently produced infection (>80%) [125].
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Since the femur of the rabbit is a larger and thicker bone than the tibia, and
particularly since it has a larger medullary canal, it is also often used in rabbit
osteomyelitis models as it is easier for implant fixation [126]. An early femoral
model was one published by Rodeheaver et al. in which they inoculated into the
femoral intramedullary canal through a hole drilled in the medial femoral condyle
[127]. Fracture is often unnecessary in the investigation of foreign material
response, however several models have been since adapted from the original
models by Scheman and Norden to include the introduction of fracture to examine
bone healing responses.

In another study by Arens et al. in 1996 [128], they modified the Worlock et al.
method and implanted stainless steel and titanium 6-hole 2.0 mm DCPs on the
tibiae of rabbits and inoculated with varying concentrations of bacteria. To
inoculate, the DCP was implanted and the wound was partially closed before a
sialography catheter and needle was used to directly inject 100 µl of S. aureus
suspension. The rabbits were radiographed and kept in separate housing for 28
days, with daily wound examination and weekly temperature and weight
monitoring. After the 28-day period, the rabbits were killed and the implants, bone,
and surrounding soft tissue were harvested under sterile conditions. The implants
were rolled across tryptone soya agar (TSA) to be evaluated qualitatively and the
bone and soft tissue specimens were evaluated quantitatively. Infection was defined
as a positive finding of bacteria in this analysis. This study design was used as a
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model for the present research presented in this dissertation, and the conclusion
from this study that the rate of infection for stainless steel plates (75%) was
significantly higher than the rate of infection for titanium plates (35%) (p<0.05)
influenced our decision to choose titanium as the base implant material in the
present study over stainless steel.

Research Outcomes
As mentioned previously, the titanium alloy samples with the high power 9-layer
BioDep™ deposition of vancomycin and chitosan was chosen as the optimal
treatment to inhibit bacteria based off the Kirby-Bauer zone of inhibition testing.
It was hypothesized that titanium implants modified with high powered 9-layer
chitosan and vancomycin deposition but with no CoBlast™ modification would
prevent infection in rabbits more effectively than traditional titanium implants to be
used in the animal study due to the lack of antibiotic present and those with an
alumina-only CoBlast™ modification combined with the high powered 9-layer
chitosan and vancomycin BioDep™ deposition due to the added surface roughness
that could harbor bacteria by providing a larger surface area for attachment. To
prove this, a pre-pilot, pilot, and full animal study were developed. The Clemson
University Institutional Animal Care and Use Committee (IACUC) as well as the
Animal Care and Use Review Office (ACURO) had previously approved these animal
experiments.
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Pre-Pilot Study
Surgical protocol
2 6-hole stainless steel dynamic compression plates (DCPs) were obtained from
Smith & Nephew. Neither were treated with CoBlast™ or BioDep™ as the intention of
this pre-pilot study was to confirm surgical methods and verify proper tools were
acquired.

2 male New Zealand white rabbits, weighing 3-4 kg, were used in this portion of the
study, with one undergoing inoculation and the other kept sterile during
implantation. After an acclimation period of 14 days, one rabbit was inoculated with
1000 cells of S. aureus (ATCC 25923) and the other received 50 µl of phosphate
buffered saline (PBS) as a sterile control. Immediately post-implantation and one
week later the rabbits were radiographed and their incision sites were examined for
any signs of infection. The rabbits were kept in single-housing units and after 11
days the rabbits were euthanized with an intravenous injection of sodium
pentabarbitol solution and the femurs and implants were harvested.

The rabbits were anesthetized with isoflurane and the left hind leg was shaved and
aseptically prepared for surgery. After lateral femoral exposure, a partial
transection of the femur was made and a 6-hole stainless steel DCP (Smith &
Nephew, Memphis, TN, USA) was implanted using six 1.5 mm diameter titanium
screws (Narang Medical, Ltd., New Delhi, India). 50 µl phosphate buffered saline
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(PBS) in control groups or 50 µl of previously described inoculum in the inoculation
groups was placed directly along the implants of rabbits prior to closure with
sutures.

Weekly examinations
Radiographs confirmed proper implantation and no fractures along the femurs of
the two rabbits, as seen in Figure 60.

Figure 60: X-ray images immediately post-op in pre-pilot study

Histology
Histological slides from the pre-pilot animal study were examined with an optical
microscope. Artifacts from the sectioning process were noted and will be avoided in
future sectioning. Samples were processed by histologist Chad McMahan using the
Donath bone processing procedure. The final polymerization step was done using
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glycidyl methacrylate (GMA) and stained with methylene blue basic fuchsin (MBBF)
to show osteogenic morphology. Macro images from this process can be seen in
Figure 61 and Figure 62.

Figure 61: Prepared histological slides prior to staining

Figure 62: Histological slide after methylene blue basic fuchsin (MBBF) staining
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The results of MBBF staining is that bone will stain a bright pink and the
surrounding soft tissues will stain a blue-purple. The intention of this staining was
to examine the bony growth into the threads of the screws after implantation, with
the hypothesis that the bone would successfully begin to form into the threading in
a healthy model, but not in an infected tissue. An example of these histological
images can be seen in Figure 63, Figure 64, and Figure 65, with additional images
found in Appendix E.

Figure 63: Methylene blue basic fuchsin (MBBF) staining on contralateral femur as a control
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Figure 64: Methylene blue basic fuchsin (MBBF) staining of inoculated surgical femur

Figure 65: Methylene blue basic fuchsin (MBBF) stain of screw threads in inoculated surgical femur
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It should be noted that these slides are from the pre-pilot animal study, which lasted
a total of 11 days, instead of the 28 days that the full study will last. This could be a
reason for the lack of bony growth seen in these samples. Additional limitations to
the histological assessment included that each screw was not perfectly in the same
plane as the others and therefore it could not be determined if some gaps seen in
between tissues a result of this or due to the lack of bone growth towards the
implants.

Discussion: Pre-pilot study
The primary purpose of the pre-pilot study was to provide the opportunity for the
surgeons to test out the surgical protocol and ensure that everything went smoothly
and no unforeseen complication arose. This study was condensed (11 days as
opposed to the 28 days that the pilot and full study would be) so many results
acquired could not be used for any final data. This study yielded no significant signs
of infection, so discussions of increasing the bacterial concentration from 1000 cells
to 5000 started. It was decided that we should add an examination of if bacteria had
moved to the bloodstream so a Brown and Brenn histology stain was added to the
pilot study protocol. The histology results did not yield anything significant but
since this was a shortened study, nothing was changed for the pilot study. This study
also used spare DCPs acquired by one of the collaborating surgeons, so the number
of holes and material type (stainless steel) was different from what would be used in
the pilot study. This study did help the surgeons plan out their methods in surgery
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as well as help the staff at the research facility to plan how to do weekly
examinations with so many rabbits at the same time as well as properly X-ray the
femur to identify quality implantation.

Pilot Study
Materials
32 mm long 5-hole titanium DCPs were obtained from Narang Medical, Ltd. Some
implants were left as received as controls and some were treated with either the
CoBlast™ process, developed by ENBIO, Ltd. (Dublin, Ireland), or with the CoBlast
treatment in combination with the BioDep™ process, developed by TheraDep (San
Jose, CA). CoBlast™ is a surface modification technique that microblasts an abrasive,
in this study alumina powder (Al2O3, d50=100 µm), at a pressure of 90 psi out of a
circular nozzle (1.2 mm diameter, Comco, Inc.) at room temperature. The BioDep™
process is a plasma deposition of chitosan and vancomycin onto the surface.
Materials were sterilized using ethylene oxide prior to implantation.

Implant preparation
In the pilot study, 6 implants were separated into three primary groups: 2
unmodified titanium DCPs, 2 titanium DCPs modified with the CoBlast™ process,
and 2 titanium DCPs modified with the CoBlast™ process and BioDep™ process. One
of each group was inoculated and the other was kept sterile. The pilot study was
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used to confirm inoculation concentration, implant size, and surgical technique and
the full study that followed increased animal numbers for statistical significance.

Surgical protocol
6 male New Zealand white rabbits, weighing 3-4 kg, were randomly assigned to one
of three treatment groups (n=2). After a 14-day acclimation period in single
housing, one rabbit in each of the treatment groups was inoculated with 1000 cells
of S. aureus (ATCC 25923) and the other three left sterile as controls. The three
implant types used in each of these treatment groups were unmodified titanium
DCPs, titanium DCPs modified with the BioDep™ process, or titanium DCPs modified
with the CoBlast™ and BioDep™ techniques. The surgical femurs were radiographed
and their incision sites were examined weekly for any signs of infection. After 28
days, the rabbits were euthanized with an intravenous injection of sodium
pentabarbitol solution and the femurs and implants were harvested.

The rabbits were anesthetized with isoflurane and the left hind leg was shaved and
aseptically prepared for surgery. After lateral femoral exposure, a partial
transection of the femur was made and a 5-hole titanium DCP (Narang Medical, Ltd.,
New Delhi, India) was implanted using four 1.5 mm diameter titanium screws
(Narang Medical, Ltd., New Delhi, India). 50 µl phosphate buffered saline (PBS) in
control groups or 50 µl of previously described inoculum in the inoculation groups
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was placed directly along the implants of rabbits prior to closure with sutures. The
surgical procedure and subsequent actions are depicted in Figure 66.

Figure 66: Animal study flow chart for pilot and full studies

Weekly examinations
Immediate post-operative x-rays were taken to confirm proper placement and no
fractures, as seen in Figure 67.

114

Figure 67: X-ray images immediately post-op in pilot study

After 28 days, the femurs were harvested as seen below in Figure 68.

Figure 68: Images of harvested femurs 28 days post-op (pilot study)
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Following explantation, there were some signs of a tissue response to infection
including the formation of a protective tissue barrier encasing the implant, however
this could not be verified from tissue collection.

Histology
Histological techniques identical to those described on page 108 were performed for
the rabbit femurs harvested in the pilot study. These images can be seen in Figure
69 and Figure 70.

Figure 69: Methylene blue basic fuchsin stain on sterile control (TB control)
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Figure 70: Methylene blue basic fuchsin (MBBF) stain on inoculated femur (TB inoculated)

It was found that there was no discernable difference in bony growth occurring
between sterile controls and the inoculated femurs so hard tissue histological
analysis was abandoned for the full study.

Discussion: Pilot study
The pilot study was a useful dry-run of the full study setup in which the implants to
be used in the final study were implanted for 28 days. The biggest difference
between the pilot study and the full study was the number of rabbits used and
inoculum concentration. Only 6 rabbits were used and the inoculation concentration
was still 1000 cells. Due to the lack of obvious infection signs following explantation,
the recommendation to use 5000 cells of S. aureus was made. Additionally, histology
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did not provide any useful information and these techniques were abandoned for
the final study. The screws were difficult to implant which led to the surgeon’s
recommendation for larger screws in the full study.

Full Study
Surgical protocol
42 male New Zealand white rabbits, weighing 3-4 kg, were randomly assigned to
one of six treatment groups (n=7). Three of the treatment groups were inoculated
with 5000 cells of S. aureus (ATCC 25923) and the other three left sterile as controls.
The three implant types used were identical to those of the pilot study. Blood draws,
x-rays, and wound examination occurred on the same schedule as the pilot study.
After 28 days, the rabbits were euthanized with an intravenous injection of sodium
pentabarbitol solution and the femurs and implants were harvested.

118

Figure 71: Images of the plates from the three treatment groups to be used in the study (untreated top
left, vancomycin treated TBVHP9 top right, and CoBlast™ and vancomycin treated bottom)

The full study was performed over the course of 4 surgical days due to the quantity
of rabbits that could not all be performed in a single day by the two performing
surgeons. In the first surgery, the rabbits were anesthetized with isoflurane and the
left hind leg was shaved and aseptically prepared for surgery. After lateral femoral
exposure, a partial transection of the femur was made and a 6-hole titanium DCP
(Narang Medical, Ltd., New Delhi, India) was implanted using six 2.0 mm diameter
titanium screws (Narang Medical, Ltd., New Delhi, India), which was different
diameter from the pilot study due to difficulty implanting the screws in the pilot
study. 50 µl phosphate buffered saline (PBS) in control groups or 50 µl of previously
described inoculum in the inoculation groups was placed directly along the implants
of rabbits prior to closure with sutures. After the first surgery, 6 of the 12 rabbits
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fractured their femurs along the screws due to the large size and quantity of screws
implanted. Future surgeries used only four 1.5 mm diameter titanium screws,
similar to the pilot study, to alleviate this issue. An additional rabbit was added to
the inoculated DCP with BioDep™ and CoBlast™ treatment groups and 2 additional
to the treatment group using a DCP with BioDep™ modification to maintain
statistical significance. In total, the number of rabbits operated on in each group of
the full study can be seen in Table 25.
Table 25: Number of rabbits in each treatment group

CONTROL
INOCULATED

UNMODIFIED
DCP
7
7

DCP WITH
BIODEP™
7
9

DCP WITH BIODEP™ AND
COBLAST™
7
8

Explantation procedure
After 28 days, the rabbits were euthanized and the femurs with intact implants were
harvested. In the full study, screws were removed and placed in PBS for bacterial
analysis. The DCPs were also removed from the bone and placed in separate
containers of PBS for bacterial analysis. One implant from each of the inoculated
treatment groups was reserved for scanning electron microscopy (SEM) instead of
bacterial viable cell count analysis. Finally, tissue adjacent to the implant was
removed and placed in sterile tubes of PBS to examine if bacteria spread past the
surface of the implant.

Fracture analysis
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Due to difficulties implanting the screws in the pilot study, the screw diameter was
increased to 2.0 mm and lengths varied from 10-12 mm. 6 titanium screws were
implanted with a 6-hole plate provided from Narang Medical, Ltd. For this first
round of surgeries, 12 rabbits received one of the treatments (TB (unmodified),
TBV, or TA5CV9), with 4 being in each group.

Figure 72: X-ray images immediately post-op in full study, first 12 rabbits only

During implantation, surgeons noted signs of bone cracking, which was confirmed
with x-rays showing a fracture in the posterior cortex of 3 rabbit femurs, as seen in
Figure 73.
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Figure 73: Close-up x-ray image showing fracture from screw during implantation

Despite these fractures, the leg was stable and the rabbits were just monitored for
any further issues. After the rabbits woke up from the anesthesia, 2 broke their legs
immediately, and throughout the next 2 weeks 4 more did the same. These fractures
did not directly correlate with the implantation fractures, and after further
examination it can be seen that the rabbits fractured down the screw line. It was
suspected that this was due to the quantity and size of the hardware implanted and
seemingly had no correlation to whether or not it had fractured on the poster cortex
during implantation, so further tests in the laboratory were done to examine this.
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Throughout the 28-day duration of the full animal study, 6 rabbits fractured their
femurs and were euthanized. 5 of these femurs were retrieved and analyzed for
fracture patterns. The femurs can be seen in Figures 10-14.

Figure 74: Rabbit 3R1 fractured femur

Figure 75: Rabbit 3R3 fractured femur
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Figure 76: Rabbit 3R5 fractured femur

Figure 77: Rabbit 3R6 fractured femur
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Figure 78: Rabbit 3R10 fractured femur

3 contralateral femurs were retrieved from lost rabbits from the full study and used
for testing. 1 femur was left intact as a control, 1 femur was implanted with (4) 1.5
mm titanium screws and a dynamic compression plate (DCP) to mimic the
implantation method from the pilot study, and 1 femur was implanted with (6) 2.0
mm titanium screws and a DCP to mimic the full study.

Figure 79: (Left to right) Unmodified femur, femur implanted with 4 screws, femur implanted with 6
screws

The ends of these bones were fixed in a resin. One end was clamped down and the
other end was twisted with a digital torque wrench that was recording the peak
torque experienced. Since long bones are weakest in torsion, we chose this method
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to most easily break the bones. The intact and unmodified femur was broken with
4.2 N-m of force.

Figure 80: Before and after fracturing the unmodified femur

Both the femur with 6 screws and the femur with 4 screws broke without a reading
from the torque wrench (meaning the torque needed to break the bone was less
than the lower limit of the torque wrench’s capability, 2.5 N-m), however there are
some things to note from the testing. The femur with 6 screws implanted broke
almost immediately upon movement of the torque wrench, with a quiet crunching
noise and almost no resistance. The femur with the 4 screws took slightly more
movement of the torque wrench to break and when it did it was a loud pop/crack,
much more similar to the sound of the unmodified femur. I believe this to be the
sound of the bone breaking whereas the 6-screw femur didn’t have much bone to
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break because the screws had already formed a significant fracture line ready to
break. This is somewhat evidenced in the images of the 6-screw femur break where
you can see full exposure of a few of the screws.

Figure 81: Fracture of the femur implanted with 6 2.0 mm screws

Finally, examining the fracture of the 4-screw femur it can be seen that a fracture
occurred between the 2 centered screws.

Figure 82: Fracture of the femur implanted with 4 1.5 mm screws
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Figure 83: Alternative view of the fracture of the femur implanted with 4 1.5 mm screws

Although we are unable to test a femur with an implant using the 1st, 2nd, 5th, and
6th holes as alternative screw placements, it would probably not be the best
orientation of screws since there would be two sites of screws right next to each
other and double the risk of fracture between close screws (using the 1st, 2nd, 5th,
& 6th holes could induce a fracture between the 1st and 2nd holes as well as
between the 5th and 6th holes, whereas using the current configuration of screws
placed in the 1st, 3rd, 4th, & 6th holes, it is more likely the fracture would only be at
higher risk between the 3rd and 4th holes).
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In summary, 6 of 12 rabbits severely fractured their legs after implantation of 6 2.0
mm diameter screws and a DCP. After analysis of the fractures, it was determined
the fracture was most likely caused by a weakened line in the bone caused by the
large screws penetrating the second more posterior cortex of the bone. When
comparing to the use of 4 1.5 mm screws as in the pilot, it was found that the bone
did not fracture in vivo and in laboratory testing a more audible break, that did not
follow any screw line in propagation. Through examination of the fracture in the
laboratory break of the 4 1.5 mm screw implanted femur it was noted that the
fracture traveled between the 2 closest screws, leading to our decision to keep
screws in the orientation tested as opposed to implanting the screws in holes 1, 2, 5,
and 6 because two sites of screws in close proximity to each other would be present
and concerning. All in all, it was determined that the large diameter and high
quantity of screws were too much for the size of the rabbit femurs and from these
findings our recommendation is to use the (4) 1.5 mm screws in holes 1, 3, 4, and 6
for the remainder of the full study.

Weekly examination methods
-

Visual examination and radiography

X-rays were taken post-operatively to confirm proper implantation and examined
weekly to verify the femur and implant were healing and positioned properly. Visual
documentation and examination took place on explantation days. Identification of
signs of infection, including redness, swelling, development of pus or a capsule
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surrounding the implant, and cloudiness of the tissues, were used to help determine
the effectiveness of treatments.

Figure 84: Signs of infection in rabbit #25 (unmodified implant) with pus in the tissues

Figure 85: Explant and surrounding tissues of rabbit #37, titanium implant with BioDep™ modification,
without signs of infection
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Figure 86: X-ray of rabbit from full study showing correct positioning of the DCP

-

Histology

Instead of hard tissue histology, a modified Brown and Brenn stain was done on
blood smears to look for the presence of bacteria in the blood. In this stain gram-
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positive bacteria stain blue, gram-negative bacteria and nuclei stain red, and the
background is yellow. Several of these features can be identified in Figure 87, and it
can be seen that there were no gram positive bacteria, such as the S. aureus, present
in the blood, as expected.

Figure 87: Rabbit 3R7 blood smear stained with a modified Brown and Brenn stain

This technique was discontinued after the first surgery of the full study because
rabbits are not likely capable of surviving an infection severe enough to show
bacteria in the blood through this study.

-

White blood cell counts

Weekly blood draws were analyzed for white blood cell count as a sign of a possible
systemic infection response from the rabbit. Just prior to surgery, the average white
blood cell count (x109/L) was 8.03 (SD=2.24). There was no significant change in
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the following weeks: week 1 was 8.81 (SD=1.83), week 2 8.62 (SD=1.55), week 3
8.14 (SD=1.63), and week 4 7.38 (SD=1.62), indicating no significant changes in
systemic response to infection were seen.

-

High-Performance Liquid Chromatography: Work by Shayesteh Beladi

To confirm that the localized release of the antibiotic vancomycin from the BioDep™
treated

implants

did

not

move

systemically,

high-performance

liquid

chromatography (HPLC) was performed on the blood drawn pre-operatively and 0,
3, 6, 18, 24, 48 hours post-operatively. The results of this study are being currently
analyzed by fellow graduate student Shayesteh Beladi, however have not yet been
completed. These results will settle any concerns about this treatment moving
systemically and causing concern similar to the use of oral antibiotics.

Bacterial cell recovery methods
All inoculated explants, with the exception of n=1 from each treatment group, were
used in viable cell count analysis to determine the number of bacteria on the surface
of the implant, the surface of the screws, and in the surrounding soft tissue.

-

Viable cell count protocol: Work by Shayesteh Beladi

Shayesteh Beladi, a collaborating graduate student in the biological sciences
department at Clemson University, performed all the viable cell count work for this
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study. A summary of her work is included here as it is pertinent to the end
conclusions of the research:

Soft tissue from the area surrounding the implant was placed in pre-weighed 50 ml
sterile centrifuged tubes. These tubes were then weighed again to determine the
weight of the recovered soft tissue. 4 ml PBS was added to each tube and tissues
were homogenized on ice using the maximum setting for 30 seconds or until they
appeared homogenized. They then sat on ice for 5 minutes to yield supernatant.
Serial dilutions on the supernatant were then serially diluted 10-1, 10-2, 10-3, and 104

fold. 100 µl from each dilution as well as the undiluted sample were plated on

tryptic soy agar (TSA) blood agar plates and incubated at 37°C for 48 hours.

To get a viable cell count for the explanted DCPs and screws, they were rinsed with
PBS three times and placed into 15 ml sterile conical tubes with 4 ml PBS. Each tube
was then sonicated for 5 minutes and this first wash solution (W1) was serially
diluted 10-1, 10-2, 10-3, and 10-4 fold and 100 µl from each undiluted and diluted
sample was plated on TSA and incubated at 37°C for 48 hours. A second wash (W2)
with 5 ml PBS in an ultrasonic water bath for 5 minutes was performed. A third
wash (W3) was performed and viable cell counts on W2 and W3 were done in the
same manner as previously described for W1.

-

Results and discussion: viable cell count analysis
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The bacteria recovered from the surrounding soft tissue, explanted DCPs, and
explanted screws can be found in Table 26.
Table 26: Bacteria recovery from DCP, screws, and surrounding soft tissue

Rabbit #

Plate received Bacteria
Bacteria
Bacteria
recovered
recovered
recovered
from tissue
from explant
from screws
(CFU/g)
(cells)
(cells)
25
unmodified
7.80E+04
N/A*
3.40E+02
26
unmodified
0
3.32E+03
1.80E+02
27
unmodified
0
2.56E+03
3.20E+02
40
unmodified
1.40E+04
3.36E+03
2.20E+02
41
unmodified
2.90E+04
8.66E+04
3.86E+04
42
unmodified
0
1.61E+04
1.00E+03
43
unmodified
0
1.29E+05
1.06E+03
* This implant was used for SEM imaging and therefore could not be used for viable
cell count analysis.
Rabbits 40 and 41 were euthanized due to unanticipated post-surgical fractures,
however their femurs were still harvested for viable cell count and included in this
analysis. All recovered bacteria came from rabbits that had received the unmodified
titanium implants, however not every rabbit that received an unmodified titanium
implant showed signs of bacteria present.

-

Materials and methods: SEM confirmation of cleaning methods

One recovered DCP from each of the inoculated treatment groups was used for SEM
imaging instead of used for viable cell count analysis. These explants underwent a
critical point drying (CPD) procedure to sufficiently dry the tissues on the samples
for SEM analysis. They were first primarily fixed using 2.5% glutaraldehyde in
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distilled water followed by three washes in distilled water. The secondary fixation
was with 1% osmium tetroxide in distilled water and three washes with distilled
water. Finally, the explants were dehydrated with ethanol washes that were
evaporated overnight. Following this drying process, the explants were mounted
using carbon conductive double-faced adhesive tape and sputter coated with
platinum and stored in a desiccator cabinet.

The explants were then examined for bacteria on the surface at low and high
magnification SEM (S-4800, Hitachi) and compared to explants that had been used
in the viable cell count analysis and had been thoroughly cleaned to confirm
complete removal of any bacteria from the surface. In addition, these explants were
compared to unused, sterile implants of the same type. All implants examined were
sputter coated with platinum prior to imaging.

-

Results and Discussion: SEM confirmation of cleaning methods

The entire implant that was used in the animal model was imaged and can be found
in Figure 88.

Figure 88: TB implant SEM images stitched together
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S. aureus cells could be found on each of the treatment group explants immediately
following explantation, despite not being able to recover any during the viable cell
count analysis. This could be due to the bacteria harboring in the remaining soft
tissue on the implant and not being retrievable, or that it was such a small amount
of colonies that they were not recovered during the washing steps during viable cell
counting. After washing the explants three times, one explant from each treatment
group from the viable cell count analysis was examined with SEM to determine if the
bacteria had been fully recovered during viable cell count testing. No bacteria could
be found during imaging, and comparison images can be seen in Figure 89.
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Figure 89: SEM comparison of 3 implant treatments pre-implantation, post-explantation, and after
bacterial removal

To confirm that there was not a lack of bacteria due to it being destroyed during the
CPD step, S. aureus was cultured on one unmodified implant in vitro and imaged, as
seen in Figure 90. More SEM images of this implant as well as the explants from the
full study can be found in Appendix F.
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Figure 90: Staphylococcus aureus growing on an unmodified titanium implant (in vitro culture)

Torque-out testing
The most distal screw from each of the rabbits that completed the intended duration
of the study were removed using a digital-measuring torque screwdriver. These
results were intended to be used as an added confirmation of lack of
osseointegration, possibly indicating infection. A typical output from this extraction
process looked like Figure 91.
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Figure 91: Example output of screwdriver after explanting a screw
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The peak torque experienced was recorded and these values were averaged among
the rabbits with the same treatment—rabbits kept as sterile controls versus rabbits
inoculated with the S. aureus pathogen, as seen in Figure 92.

Figure 92: Max extraction torque comparison of the screws explanted in each of the groups
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This data proved to be statistically significant (p<0.05), that the sterile screws were
significantly harder to extract, however since this data included the rabbits from the
first surgery that had 2.0 mm diameter screws as opposed to the 1.5 mm diameter
screws used for the rest of the study, the data from these rabbits was then removed
and graphed in Figure 93.

Figure 93: Max extraction torque comparison of the screws explanted in each of the groups for 1.5 mm
diameter screws only

There was no statistical significance found between these two groups (p=0.10),
indicating that the maximum torque needed for extraction was not significant
enough to detect limited osseointegration from infection. There were many
variables that could have affected the torque readings recorded, including difficulty
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explanting the screws due to the heads of the screws stripping and some tissue
overgrowth that may have falsely affected the readings. In addition, as with working
with any torque-measuring equipment it is important to keep the tool perfectly
perpendicular to the screw so as to get a proper reading, however it is possible that
with the difficulty of the screws being stripped, this screwdriver was not always
held perfectly perpendicularly and the measurements could be off.

Discussion: Full study
The full study had two stages to it: the first, which used 6 2.0 mm screws and the
second, which used 4 1.5 mm screws. Most of the data from the first stage could not
be used because 50% of the rabbits did not survive due to leg fracture from the
excessive hardware in the femur. Methods such as torque-out analysis and blood
smears did not yield any conclusive signs of infection. White blood cell counts
showed that none of the infections seemed to move systemically and induce a white
blood cell response to the infection. Other new methods such as the viable cell count
and SEM imaging provided very insightful results. The viable cell count analysis
showed that all 7 inoculated unmodified plates (TB) had bacteria growing on the
surface of the explant, yet no bacteria was recovered from any of the treated
implants. SEM confirmed that the plates were successfully cleaned in the washing
process of the viable cell count, ensuring that all possible bacteria that could have
been on the plates was retrieved. This animal model very closely followed another
study by Arens et al. in 1996 [128] and yielded useable viable cell count results,
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although not comparable due to that study examining the bacterial resistance of
unmodified stainless steel versus titanium using a different inoculum concentration.
This current model is a viable protocol for future animal research on these
treatments as it follows the progression of studies in literature and yielded
informational results.

Discussion
The pre-pilot and pilot studies confirmed the surgical protocol and yielded no
significant complications. From these preliminary studies the bacteria concentration
was raised from 1000 to 5000 cells of S. aureus. Additionally, the screw size and
quantity changed from 4 1.5 mm screws to 6 2.0 mm screws then back to 4 1.5 mm
screws in a 6-hole DCP to minimize the hardware in the femur to help prevent
unintentional femur fracture. Throughout all studies X-rays confirmed proper
implantation and did not show any signs of complication from the surgery. Upon
visual examination of the incision site externally, there were no significant signs of
infection, however upon retrieving the explants, some signs could be noted
including pus and thickening encapsulation around the implant worse than a normal
immunological response. These signs of infection were confirmed with various
bacteria tests in the laboratory, including testing the surrounding soft tissue, the
explant surface, and the explanted screws. Examination of the explant surfaces
yielded bacteria on all unmodified titanium explants and no bacteria were
recovered from the titanium explants modified with BioDep™ or CoBlast™ and
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BioDep™. The explanted screws yielded the same results. Bacteria was recovered
from the surrounding tissue in three of the rabbits that were inoculated, showing a
spread of bacteria past the surface of the implant and a possible start of a more
serious infection. There was no significant difference in effectiveness between
treatments, however both treatments were significantly more effective than no
treatment at all at preventing biofilm formation. This biofilm formation on the
unmodified titanium implants when the treated implants were able to prevent
biofilm formation is promising for these treatments.

This animal model proves to be consistent with other animal models that examine
different biofilm prevention therapies in orthopaedic implantations. Although the
original goal of this research grant was to not only examine the biofilm prevention
properties of these treatments but also bone healing properties, a fracture for a
future study may not be necessary. Like in the research by Moriarty or Arens [122,
123], not all studies examining orthopaedic infection using a fracture model. An
alternative would be similar to what Arens et al. did using a 6-hole dynamic
compression plate (DCP) for fixation on the non-fractured tibia and with only
unicortical screws. There are also periprosthetic infection studies such as a rat
model by Antoci et al. [129] where the efficacy of their covalently-bound
vancomycin titanium rods was evaluated in 12 rats and they found that there were
reduced signs of infection and bacterial load in their treatment groups, however this
was a long-term release, whereas our treatment release is very quick (<48 hours).
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Adams et al. [130] also used a rat model to determine the efficacy of their treatment,
a vancomycin-loaded sol-gel coating, and they found that the treatment decreased
the bacterial count and adhesion up to 21 days. This research too was interested in a
long-term release, the opposite of the present research. Other past research that
used animal models to study vancomycin treatment using internal fixation included
a rabbit model by Giaveresi et al. in 2008 [131] and an ovine model by Stewart et al.
in 2012 [132]. Giaveresi et al. examined the efficacy of a gentamicin-vancomycinimpregnated PMMA coating nail and found that their treatment was more successful
than the control option, however in contrast to the present work, they implanted the
nails after infecting the rabbits with methicillin-resistant Staphylococcus aureus
(MRSA) and surgically debriding the area, so this research examined the efficacy of
their therapy after an infection was already present. The current research is focused
on the prevention of bacterial adherence and biofilm formation, not the eradication
of an already-present bacterial issue. The current research is very comparable,
however, to the ovine model set up by Stewart et al. where 9 sheep were used to
examine the efficacy of a vancomycin-modified implant on both biofilm formation
and bone healing over three months. They found that the treatment supported bone
healing and inhibited bacterial colonization, however they didn’t look at the length
of release and were concerned about the emergence of resistance. This reiterates
the concern of the development of antibiotic resistance from a long-term release of
an antibiotic therapy and the importance to ensure a quick and full release of
antibiotics at a high therapeutic level.
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CHAPTER SIX
CONCLUSIONS AND RECOMMENDATIONS

Infections at the site of implantation are often difficult to treat, especially since
systemic delivery of antibiotics often results in an insufficient delivery to the site of
interest. Localized treatment of the implanted biomaterial is an alternative
treatment for this infection issue. Surface treatments can include antibiotics,
hydroxyapatite, silver and zinc ions, strontium, chitosan, bioglass and other
bioceramics [133, 134, 135, 136]. A caution to the use of antibiotics surrounds the
concern of developing antibiotic resistant bacteria, a result often of a prolonged
elution period at low therapeutic levels (below the minimum inhibitory
concentration) that allows for mutation and resistance by the bacteria. The
following conclusions provide support for the use of the BioDep™ plasma deposition
process as a viable surface treatment option to successfully deter bacterial
attachment to implants.

Material Characterization
Material characterization assessments examined the surface roughness, wear
resistance, and wettability of the CoBlast™ and BioDep™ surface modifications. The
surface roughness of stainless steel and titanium alloy samples could be directly
affected by the particle size of the abrasive used in the CoBlast™ process and was
not significantly affected by the BioDep™ deposition. The CoBlast™ surface
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modification also successfully improved the wear resistance of the samples,
regardless if their base material was stainless steel or titanium alloy. Finally, the
inclusion of the dopant PTFE in the CoBlast™ process increased the hydrophobicity
of the samples, regardless of their base material. All of these characterizations
influenced recommendations for parameters for different future applications of
these surface modification techniques.

Due to the very rough surface of the CoBlast™ modified samples, the CoBlast™
modification in its current state would not be recommended for use on materials
intending to prevent bacterial adhesion. Several groups have shown that rougher
surfaces are more prone to bacterial adhesion, however some have shown that a
surface modified to a nanoscale roughness decreases likelihood of cell attachment.
An investigation into the effect of CoBlast™ using nanoscale abrasive particles would
be recommended if there is interest in using the CoBlast™ modification for one of its
other benefits and bacterial resistance is desired.

A wear test on alumina-only CoBlast™ modified samples (A5C and A9C) would be a
recommended future analysis to compare to the CoBlast™ modifications that also
used PTFE to see what the effect of PTFE is on the wear resistance of the CoBlast™
treatment. In addition, performing a longer wear test on all samples to see if any
changes in coefficient of friction would appear after the wear test successfully
breached the CoBlast™. This would also be evaluated with energy dispersive X-ray
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spectroscopy to determine if there is a clearer indication of the full removal of the
CoBlast™ layer through elemental analysis.

In vitro Bacteria Work
In vitro analysis of the BioDep™ deposition process yielded recommendations for
the animal study to follow. BioDep™ successfully deterred bacteria from the surface
of the material regardless if the surface below it was an unmodified stainless steel
or titanium alloy sample or a CoBlast™ modified sample, however the degree to
which it was effective was dependent on the number of layers of BioDep™ applied.
An increase in number of layers increased the zone of inhibition that formed around
the samples, however eventually too many layers caused manufacturing concerns. It
was decided that a 9-layer option deposited at a high power setting was the optimal
BioDep™ treatment for implants in the animal study.

Originally when this grant was accepted, the BioDep™ deposition process used
chitosan as a carrier to deliver the antibiotic vancomycin. Since this time, TheraDep,
the company that has continued the BioDep™ development, has improved the
plasma deposition process to not need chitosan as a carrier, allowing vancomycin to
be deposited directly. With this opens the capability to deposit more than one
antibiotic on the surface of biomaterials, allowing for combination therapies to be
pursued. There is no one antibiotic that successfully inhibits all types of bacteria, so
to cover more pathogens combination therapies are used. In future work with the
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BioDep™ deposition process, it would be highly recommended to explore
combinations of various antibiotics to develop a more successful therapy for a
broader range of bacteria types.

Animal Model
The animal study examined the efficacy of an unmodified titanium dynamic
compression plate (DCP), a titanium DCP modified with an alumina-only CoBlast™
process and a 9-layer high power BioDep™ coating of chitosan + vancomycin, and an
unmodified titanium DCP with a 9-layer high power BioDep™ coating of chitosan +
vancomycin at preventing biofilm formation after 28 days implanted on a rabbit
femur. The implants with the BioDep™ coating all successfully prevented bacterial
adhesion whereas the unmodified titanium implants did not.

There are several components to the animal study that could be altered for future
iterations of this research. It was decided that the femur did not need to be fully
fractured to still induce bone healing. Fracture is often unnecessary in the
investigation of foreign material response and as Arens et al. showed [123], using
unicortical screws to fixate a DCP to a tibia is a viable option to present a realistic
foreign body without inducing fracture. This grant was originally written with an
interest in bone healing in addition to biofilm prevention on the implant, however
due to the findings it would be recommended to pursue developing the surface
modifications to the implants to optimize them for biofilm prevention. This shift to a
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solely foreign body response model opens up other animal species such as rats as
viable options, since the size of the bone is less important. Rats are a cheaper,
smaller animal with less known complications to surgeries compared to rabbits, so
this model could be better. Although with how the current results are presented it
would be recommended to perform a dosage study that examines which of the two
current treatments performs better against various concentrations of bacteria, as
recommended in the prior section I believe a new study examining combination
antibiotic therapies would be more promising. In addition, in work done by
graduate student Shayesteh Beladi showed that the vancomycin was fully released
in 48 hours, with most of the release occurring in 24 hours. Examining ways to
increase this time period slightly, assuming a high therapeutic level of release is
maintained to discourage antibiotic resistance formation, would be a good next step
to ensure full eradication of bacteria that may enter the wound upon injury.
Additionally, developing a mechanism to encapsulate this deposited vancomycin to
delay release to fight the emergence of a secondary infection would be useful,
especially in conjunction with an immediate release like what is currently occurring.
Determining the benefits of CoBlast™ in this application could be done in vitro and
followed with a similar animal study to the Arens et al. study using unicortical
screws to implant a plate onto the tibia, or possibly the femur of a rat. I believe the
focus of the next study should be solely on biofilm prevention and not on bone
healing, allowing the study to be focused on one thing and allowing better
optimization of the coating parameters for that one goal.
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APPENDICES
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Appendix A – Wear track measurement attempted methods
Optical images of large square samples used in wear testing:

Figure B.1: SB_S02_01

Figure B.3: SP5C_S02_01

Figure B.2: TB_S02_01

Figure B.4: SP9C_S02_01

Wear Track Measurements: Wyko Optical Profilometer
Using an optical profilometer (Wyko, NT-2000), wear track profiles were attained
and measured. As seen in Figure B.5, a baseline height was established from
averaging the surface roughness of the base material, and was used to determine the
true track depth, ignoring any debris pileup.
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Figure B.5: An examination of the right edge of a wear track, used to determine the track depth

A contact profilometer (Dektak) was used to compare results with the optical
profilometer, however results were not reliable due to the stylus diameter being too
large for the roughness of the CoBlast™ modified samples. These images can be seen
in Figure B.6.

Figure B.6: Dektak results, showing a slight smoothing of the worn regions (indicated by the boxes)

Results of the optical profilometry show that the track width of CoBlast™ modified
samples worn for 1 or 10 cycles, although visible optically as seen in Figure 27,

154

cannot be measured because they did not go deep enough to penetrate the CoBlast™
portion of the surface and into the base substrate and therefore could not be
measured. Differences in track width of 50 cycle and 100 cycle wear tracks between
the blank stainless steel sample and SP5C and SP9C were considered statistically
significant (p£0.05).

Figure B.7: Average track width of stainless steel samples where * means statistically significant
(p£0.05) and ** means very statistically significant (p£0.01).

Differences in track depth of 50 cycle and 100 cycle wear tracks between the blank
stainless steel sample and SP5C and SP9C were considered statistically significant
(p£0.05). Wear testing was then continued to 200 pass runs.
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Figure B.8: Average track depth of stainless steel samples where * means statistically significant
(p£0.05) and ** means very statistically significant (p£0.01).

Due to an increasing issue with the large track width not fitting in the allowable field
of view of the optical profilometer, scanning electron microscopy (SEM) was
performed to verify and possibly more accurately determine the values of the track
width.

Wear Track Measurements: Olympus LEXT Optical Profilometer
In an attempt to more accurately measure the track widths and depths, the samples
were examined with a different optical profilometer (Olympus LEXT). This proved
to be a better method than the Wyko optical profilometer, however the measured
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widths and depths were very different from previous results, as can be seen by
examining the depths presented in Figure B.9.

Figure B.9: Wear track depth of each sample, in order from left to right 1, 10, 50, and 100 passes for each
sample, with the exception of SB

In general, with increasing cycles, the depth of the track increases, as expected,
however the samples modified with the CoBlast™ technique experience far less
wear than the unmodified stainless steel samples. The inability to definitively say if
these widths and depths were correct compared to the results from the Wyko
optical profilometer led us to try a final aerial evaluation method, scanning electron
microscopy, with the hope that this new method would allow us to more clearly
define where the edge of each track was.

Wear Track Measurements: Scanning Electron Microscopy
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The sample was placed on the stud with carbon tape and affixed to the stand, as
seen in Figure B.10. The sample height was then measured and placed in the Huvitz
SU-6600.

Figure B.10: Sample on stand for SEM analysis

Below are representative images collected of the wear tracks and sample. Figure
B.11 begins images of a stainless steel blank, subjected to various wear tests.

Figure B.11: SB_S02_01 (stainless steel blank) unworn

The following images are of the same stainless steel blank sample subjected to wear
passes.
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Figure B12: Center of track, 1 pass test, SB_S02_01

Figure B.13: Starting end of track, 1 pass test, SB_S02_01
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Figure B.14: Far end of track, 1 pass test, SB_S02_01

Figure B.15: Center of track, 10 passes, SB_S02_S01
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Figure B.16: Starting end of track, 10 passes, SB_S02_01

Figure B.17: Far end of track, 10 passes, SB_S02_01
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Figure B.18: Center of track, 50 passes, SB_S02_01

Figure B.19: Starting end of track, 50 passes, SB_S02_01
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Figure B.20: Far end of track, 50 passes, SB_S02_01

Figure B.21: Center of track, 100 passes, SB_S02_01
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Figure B.22: Starting end of track, 100 passes, SB_S02_01

Figure B.23: Far end of track, 100 passes, SB_S02_01

A titanium alloy blank sample was then examined for wear track measurements.
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Figure B.24: TB_S02_01 (titanium alloy blank), unworn

Figure B.24: Center of track, 1 pass, TB_S02_01
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Figure B.25: Center of track, 10 passes, TB_S02_01

Figure B.26: Center of track, 50 passes, TB_S02_01
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Figure B27: Center of track, 100 passes, TB_S02_01

Ball bearings used in the wear testing on the TB_S02_01 sample were also examined.

Figure B.28: Ball bearing, 1 pass
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Figure B.29: Ball bearing, 10 passes

Figure B.30: Ball bearing, 50 passes
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Figure B.31: Ball bearing, 100 passes

The following images are more of the stainless steel blank sample subjected to wear
passes.
1 pass
Center of track:

169

Starting end of track:

Far end of track:
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10 passes
Center of track:
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Starting end of track:

Far end of track:
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50 passes
Center of track:

Starting end of track:
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Far end of track:

100 passes
Center of track:
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It was not possible to measure full track width at 450x magnification for the 100
pass wear track.

Starting end of track:
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Far end of track:

Back scatter images help show that there is not an elemental change present. This
can be seen in that there is no significant change in darkness, which could indicate
change in density.
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Unworn:

1 pass:

10 passes:
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50 passes:

100 passes:
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Ball bearings used in the wear testing on the TB_S02_01 sample were examined.
1 pass:

10 passes:

50 passes:
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100 passes:

From this SEM work, measures of scratch and wear dimensions were collected. The
graphs below show the results of this analysis.
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Figure B.32: Average track width of samples analyzed via SEM

Figure B.33: Average track width of samples analyzed via SEM
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Due to the inability to see the entire wear track in the higher pass count tests
without decreasing the magnification, the edges of the wear track were not easily
identifiable and this method of determining the wear track width was abandoned. In
addition, there was no way to see the track depth using SEM, so an alternative
method to measure the track depths was explored. However, with SEM energy
dispersive X-ray spectroscopy (EDS) could be performed on the wear tracks and ball
bearings to determine if the markings shown are damage being done to the ball
bearing by the samples or if the ball bearing is picking up material from the sample
during testing. These results are discussed in a later section.
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Appendix B – MATLAB code used in coefficient of friction analysis
The following text is the MATLAB code written by Jonathan R. A. Maier and edited
by Marian S. Kennedy for the use in evaluating the coefficient of friction during
constant velocity during wear testing. This code was used to gain all COF values
from the 50 and 100 pass wear tests.
% Data analysis for CETR
% Jonathan R.A. Maier originated and later modified by M.S. Kennedy
clear
clc
% Load the data
[Data,Text]=xlsread('TP9C416pt1.xlsx');
time=Data(:,1);
velocity=Data(:,9);
friction=Data(:,11);
% Take the absolute of the velocity since CETR issues pos and neg dependant
% on direction
velocity=abs(velocity);
% Make a matrix with just the data we care about including time velociy and
% cof
TrimmedData=[time,velocity,friction];
% Culling out rows with velocity less than our threshhold
Threshhold=input('Type the abs velocity threshold in mm/s that your velocity is
above:');
[r, c]=size(TrimmedData);
FilteredData=[];
for i=1:r
if TrimmedData(i,2)>Threshhold
FilteredData=[FilteredData;TrimmedData(i,:)];
end
end
% Add a column describing what cycle it was
CycleLength=150; %[seconds]
CycleLength=input('Type the time per cycle length in seconds:');
% Initialize a new column
[r,c]=size(FilteredData);
Passes=zeros(r,1);
FilteredData=[Passes,FilteredData];
% Look through the filtered data and assign pass number
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FilteredData(:,1)=floor(FilteredData(:,2)/CycleLength)+1;
%% Calculate average velocity and average friction for each cycle
numpasses=FilteredData(end,1);
averages=zeros(numpasses,3);
% Finds where each pass starts
Starts(1)=1;
for i=2:numpasses
x=find(FilteredData(:,1)==i);
Starts(i)=x(1);
end
Ends(numpasses)=r;
for i=1:numpasses-1
Ends(i)=Starts(i+1)-1;
end
% Process the data cycle by cycle
for i=1:numpasses
% cycle number
averages(i,1)=i;
% velocity average
averages(i,2)=mean(FilteredData(Starts(i):Ends(i),3));
% velocity standard deviation
averages(i,3)=std(FilteredData(Starts(i):Ends(i),3));
% friction average
averages(i,4)=mean(FilteredData(Starts(i):Ends(i),4));
% friction standard deviation
averages(i,5)=std(FilteredData(Starts(i):Ends(i),4));
end
filename = 'ResultsCETRLRW.xls';
xlswrite(filename,averages,'1','A1');
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Appendix C – Cross sectional views of wear tracks

Figure C.1: SB 200 pass track measurements

Figure C.2: SP5C 200 pass track measurements
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Figure C.3: SP9C 200 pass track measurements

Figure C.4: TB 416 pass track measurements
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Figure C.5: TP5C 200 pass track measurements

Figure C.6: TP9C 200 pass track measurements
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Appendix D – Zone of inhibition work

Figure D.1: TP5CV HP, 12, 9, 6, & 3

Figure D.2: TBV, TP5C, TP9C, TP5CV, TP9CV
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Figure D.3: TB, TA5C, TA9C, TA5CV, TA9CV
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Appendix E: Histology images
The following images are femurs harvested from the pre-pilot study, stained with
Methylene Blue Basic Fuchsin. Implants are present in the surgical legs.
Non-surgical contralateral femurs:
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Sterile surgical femur:
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Inoculated surgical femur:
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The following images are implants and femurs harvested from the pilot study,
stained with Methylene Blue Basic Fuchsin.
Sterile TB (4x magnification):
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Sterile TB (10x magnification):
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Sterile TA5CV (4x magnification):

Sterile TA5CV (10x magnification):
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Sterile TBV (4x magnification):

Sterile TBV (10x magnification):
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Inoculated TB (4x magnification):
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Inoculated TB (10x magnification):

Inoculated TA5CV (4x magnification):
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Inoculated TA5CV (10x magnification):
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Inoculated TBV (4x magnification):

201

Inoculated TBV (10x magnification):
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Appendix F: Scanning electron microscopy images of biofilm and implants
TB implant with biofilm grown on the surface in vitro:
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204

205

Sterile TB implant (prior to implantation):

206

TB explant (TB implant post-explantation from animal study)
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208

TB explant cleaned (post-explantation, after cleaning methods for viable cell count
analysis):
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Sterile TBV9HP implant (prior to implantation):
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TBV9HP explant (TBV9 implant post-explantation from animal study)
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212

TBV9HP explant cleaned (post-explantation, after cleaning methods for viable cell
count analysis):
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214

Sterile TA5CV9HP implant (prior to implantation):

215

TA5CV9HP explant (TBV9 implant post-explantation from animal study)

216

TA5CV9HP explant cleaned (post-explantation, after cleaning methods for viable cell
count analysis):

217
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